{
 "updated": "2026-11-02",
 "about": "北美女性可穿戴硬件图谱：每家公司 / 产品的形态、AI 功能、FDA 状态（regulatory）、北美售价（price_na）、融资、估值和关键数据，每个数字附出处（src）。layer 对应 layers.json 的 code。只收北美公司或北美主推的产品，只收硬件。",
 "companies": [
  {
   "name": "Ava（Ava Women）",
   "layer": "f1",
   "url": "https://www.avawomen.com/order-cycle-tracking",
   "hq": "苏黎世（母公司 FemTec Health 在休斯顿）",
   "founded": 2014,
   "product": "Ava 生育追踪手环 / Ava 周期追踪",
   "form": "手环·手表",
   "desc": "夜间戴手环，用多项生理信号识别 5 天可孕窗和周期阶段",
   "ai_features": "用体温、静息心率、HRV、呼吸等夜间数据，算法判断可孕窗；称与 LH 试纸相比可早 4 天",
   "regulatory": {
    "v": "510(k) K200163（Ava Fertility Tracker，2021-01-19 获批）",
    "src": "https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K200163"
   },
   "price_na": {
    "v": "周期追踪版 $239（原价 $279）；生育版 Maven 渠道 $256（原价 $279）",
    "date": "2026-11",
    "src": "https://www.avawomen.com/order-cycle-tracking"
   },
   "north_america": "北美主推（依据：美元定价、官网发美国与加拿大、Maven Wallet 福利报销）；公司注册在瑞士，App 商店资料留的是得州奥斯汀地址",
   "stage": "在售",
   "total_raised": "累计融资约 $42.3M（公司 2018-05 口径，Wearable Technologies 转述；之后未再公开融资）",
   "funding": [
    {
     "date": "2015-11",
     "round": "种子轮（Swisscom Ventures 与 Zürcher Kantonalbank，无明确领投）",
     "amount": "$2.6M",
     "lead": "Swisscom Ventures、Zürcher Kantonalbank",
     "src": "https://www.unquote.com/dach/official-record/3002698/polytech-in-usd97m-series-a-for-ava"
    },
    {
     "date": "2016-11",
     "round": "A 轮",
     "amount": "$9.7M",
     "lead": "Polytech Ecosystem Ventures（Blue Ocean Ventures、Global Sources、Swisscom Ventures、Zürcher Kantonalbank 跟投）",
     "src": "https://techcrunch.com/2016/11/15/ava-the-fertility-wearable-raises-9-7m-to-help-families-conceive/"
    },
    {
     "date": "2018-05",
     "round": "B 轮（无单一领投，公司称主要由老股东出资）",
     "amount": "$30M",
     "lead": "Polytech Ecosystem Ventures、Blue Ocean Ventures、Global Sources、Zürcher Kantonalbank、Swisscom Ventures（btov Partners、SVC 跟投）",
     "src": "https://www.avawomen.com/press/ava-closes-30-million-series-b-round-and-announces-10000-pregnancies"
    }
   ],
   "customers": [
    "Maven Clinic（Maven Wallet 报销）"
   ],
   "owner": "2022-07 被 FemTec Health（美国休斯顿）收购，金额未披露",
   "note": "收购时间与金额来自聚合站和维基，没找到买卖双方的原始公告。被收购后的收入、估值没查到。官网产品页看起来仍在更新促销，但没查到公司近期的融资或财务消息。"
  },
  {
   "name": "Femometer（智能戒指 Ring Air）",
   "layer": "f1",
   "url": "https://www.femometer.com/Products/Femometer-Ring-Air-for-health-tracking-size-7",
   "hq": "新泽西州普林斯顿（聚合站 CB Insights；官网未写）",
   "founded": 2014,
   "product": "Femometer Ring Air（另有 Gen2、Gen1）",
   "form": "戒指",
   "desc": "戴在手指上夜间测基础体温，预测月经与排卵，并带睡眠、热潮红监测",
   "ai_features": "用夜间多次基础体温自动取稳定值，算法判断排卵和可孕窗；新增热潮红检测",
   "regulatory": {
    "v": "未申请（一般健康类）",
    "src": "https://m.media-amazon.com/images/I/91EnMJdUjhL.pdf"
   },
   "price_na": {
    "v": "Ring Air $199.99，无订阅费；Gen2 $159.99（原价 $199.99）",
    "date": "2026-11",
    "src": "https://www.femometer.com/Products/Femometer-Ring-Air-for-health-tracking-size-7"
   },
   "north_america": "北美主推（依据：亚马逊美国上架、美元定价、聚合站记载总部在新泽西）；母公司 Bongmi 的深圳背景没在官方资料里核到",
   "stage": "在售",
   "key_data": [
    {
     "k": "Femometer App 服务女性",
     "v": "1500 万以上（公司自报）",
     "date": "2026-02",
     "src": "https://www.kickstarter.com/projects/1012603684/femometer-ring-air-next-gen-smart-ring-for-women"
    }
   ],
   "note": "Ring Air 2026-02 在 Kickstarter 上众筹，页面显示未达标（筹到 $3,802，目标 $5,000）；之后官网已按 $199.99 直接销售。说明书写明不是医疗器械。融资、估值、收入没查到。总部位置只有聚合站来源。"
  },
  {
   "name": "Incora Health",
   "layer": "f1",
   "url": "https://www.incorahealth.com/",
   "hq": "格林维尔（南卡罗来纳州）",
   "founded": 2022,
   "founded_month": "2022-03",
   "product": "Incora 智能耳钉",
   "form": "耳戴",
   "desc": "耳钉内置体温和 PPG 传感器，用耳部数据追踪周期与排卵",
   "ai_features": "用机器学习处理耳温、心率、HRV 等数据，给出周期、排卵和睡眠洞察",
   "regulatory": {
    "v": "未申请（研究阶段，没查到 FDA 记录）",
    "src": "https://time.com/collections/best-inventions-special-mentions/7320899/incora-earrings/"
   },
   "price_na": {
    "v": "没查到（未公布售价，仅开放候补名单）",
    "date": "2026-11",
    "src": "https://time.com/collections/best-inventions-special-mentions/7320899/incora-earrings/"
   },
   "north_america": "北美公司：美国南卡罗来纳州，设计团队在硅谷",
   "stage": "临床",
   "total_raised": "早期约 $100 万（创始人、亲友、天使投资人及州与联邦拨款，报道口径）",
   "funding": [
    {
     "date": "2024-05",
     "round": "种子轮",
     "amount": "金额未披露",
     "lead": "XRC Ventures（聚合站 Tracxn）",
     "src": "https://www.cbinsights.com/company/incora-health"
    }
   ],
   "note": "TIME 2025 年度最佳发明特别提名；截至 TIME 报道时无确认发布日期，之后有没有上市没查到。Sound Media Ventures 也是投资方（聚合站）。估值、收入没查到。"
  },
  {
   "name": "kegg（Lady Technologies）",
   "layer": "f1",
   "url": "https://kegg.tech/products/kegg-fertility-tracker",
   "hq": "旧金山",
   "founded": 2017,
   "product": "kegg 生育追踪器（体内宫颈黏液传感器 + 凯格尔训练）",
   "form": "体内",
   "desc": "每天放入阴道 2 分钟，测宫颈黏液电解质变化，找出完整可孕窗",
   "ai_features": "按黏液阻抗给出生育力评分和排卵概率；没公开更多算法细节",
   "regulatory": {
    "v": "FDA 一类器械，510(k) 豁免",
    "src": "https://www.femtech-projects.jp/assets/pdf/project_report_70.pdf"
   },
   "price_na": {
    "v": "$279（标价；页面正在做限时促销与 6 个月怀孕保证，实付价没取到）",
    "date": "2026-11",
    "src": "https://kegg.tech/products/kegg-fertility-tracker"
   },
   "north_america": "北美公司：美国亚马逊、官网、MyOvaterra，FSA/HSA 可用",
   "stage": "在售",
   "total_raised": "累计约 $8.0M（本表 2020 种子轮 $1.5M + 2025 A 轮 $6.5M；聚合站 FundedIQ 同为 $8.0M）",
   "funding": [
    {
     "date": "2020-10",
     "round": "种子轮（无明确领投；参投 Crescent Ridge Partners、SOSV、Texas Halo Fund、Fermata Fund、MegaForce 等）",
     "amount": "$1.5M",
     "src": "https://www.biospace.com/femtech-company-lady-technologies-launches-kegg-the-first-2-in-1-medical-device-to-help-women-in-their-conception-journey"
    },
    {
     "date": "2025-01",
     "round": "A 轮",
     "amount": "$6.5M",
     "lead": "Relentless Consumer Partners",
     "src": "https://sosv.com/fertility-tracker-kegg-raises-6-5m-series-a/"
    }
   ],
   "key_data": [
    {
     "k": "累计服务",
     "v": "10 万以上对夫妻",
     "date": "2026-11",
     "src": "https://kegg.tech/products/kegg-fertility-tracker"
    },
    {
     "k": "服务人数（融资时）",
     "v": "5 万名女性与家庭",
     "date": "2025-01",
     "src": "https://sosv.com/fertility-tracker-kegg-raises-6-5m-series-a/"
    }
   ],
   "customers": [
    "SOSV / HAX（早期投资与孵化）",
    "伊藤忠商事（日本员工试点研究）"
   ],
   "note": "FDA 豁免这一条的来源是伊藤忠 2024 年的试点研究报告（日本语），不是 FDA 数据库，没在 accessdata 里找到对应记录。估值、收入没查到。成立年份来自聚合站，公司官网没写。"
  },
  {
   "name": "Natural Cycles（NC° Band）",
   "layer": "f1",
   "url": "https://www.naturalcycles.com/devices/nc-band",
   "hq": "斯德哥尔摩",
   "founded": 2013,
   "product": "NC° Band（夜间腕温手环，配 NC° 避孕 App）",
   "form": "手环·手表",
   "desc": "夜间测腕温，配合 FDA 认证算法判断受孕日，做非激素避孕与备孕",
   "ai_features": "NC° 算法用夜间体温个体化判断每日可孕状态，另有备孕、产后、围绝经模式",
   "regulatory": {
    "v": "De Novo DEN170052（2018-08，避孕软件）+ 多份 510(k)（K202897、K231274、K241006、K250561、K253694）",
    "src": "https://recenthealthtech.com/companies/natural-cycles"
   },
   "price_na": {
    "v": "手环单买 $129.99；年订阅含手环免费（年订阅约 $149.99）",
    "date": "2026-11",
    "src": "https://www.naturalcycles.com/devices/nc-band"
   },
   "north_america": "北美主推：美国 FDA 认证，保险报销（多数主流保险覆盖年订阅）、FSA/HSA 可用；总部瑞典，母公司在瑞士",
   "stage": "在售",
   "revenue": {
    "v": "约 9.4 亿瑞典克朗（约 $100M）",
    "date": "2025",
    "kind": "年收入，创始人在 Breakit 播客自述；另称 2022 年起盈利、EBITDA 利润率约 25%",
    "src": "https://www.breakit.se/artikel/46846/natural-cycles-grundaren-om-succebolagets-vag-till-borsen-vill-vara-forberedda"
   },
   "total_raised": "累计融资超 $95M（公司 2024-05 口径，tech.eu 转述；Exame 转述为超 $100M）",
   "funding": [
    {
     "date": "2015",
     "round": "种子轮（领投方没查到）",
     "amount": "$1.5M",
     "src": "https://techcrunch.com/2016/07/04/natural-cycles-gets-6m-to-convince-more-women-to-ditch-the-pill/"
    },
    {
     "date": "2016-06",
     "round": "A 轮",
     "amount": "$6M（SEK 5000 万）",
     "lead": "Bonnier Growth Media（Sunstone Capital、e.ventures 跟投）",
     "src": "https://www.bonnier.com/en/news/bonnier-growth-media-leads-sek-50-million-investment-round-usd-6-million-in-fertility-app-natural-cycles/"
    },
    {
     "date": "2017-11",
     "round": "B 轮",
     "amount": "$30M",
     "lead": "EQT Ventures（Sunstone Capital、e.ventures、Bonnier Growth Media 跟投）",
     "src": "https://www.mobihealthnews.com/news/certified-contraceptive-app-natural-cycles-raises-30m"
    },
    {
     "date": "2024-05",
     "round": "C 轮",
     "amount": "$55M",
     "lead": "Lauxera Capital Partners（Point72 Private Investments、EQT Ventures、Samsung Ventures、Heartcore Capital、Headline、Bonnier Ventures 跟投；另有 J.P. Morgan 循环信贷额度）",
     "src": "https://www.finsmes.com/2024/05/natural-cycles-closes-55m-series-c-financing.html"
    }
   ],
   "key_data": [
    {
     "k": "注册用户",
     "v": "600 万以上",
     "date": "2026-10",
     "src": "https://www.naturalcycles.com/"
    },
    {
     "k": "覆盖市场",
     "v": "35 个以上国家（含加拿大）",
     "date": "2026-08",
     "src": "https://www.naturalcycles.com/uk/about"
    }
   ],
   "note": "FDA 认证的对象是 App 算法；NC° Band 2025 年发布，官网说同样可用 Oura、Apple Watch、Garmin 的夜间体温。手环本身有没有单独的 FDA 记录没查到。估值没查到。FDA 清单来自聚合站对 FDA 数据库的整理，未逐条打开 accessdata。"
  },
  {
   "name": "Tempdrop",
   "layer": "f1",
   "url": "https://www.tempdrop.com/products/tempdrop-gen2",
   "hq": "特拉维夫",
   "founded": 2014,
   "product": "Tempdrop 2.0（上臂睡眠测温）",
   "form": "腋下·臂戴",
   "desc": "夜间戴在上臂连续测基础体温，免晨起测温，判断排卵与可孕窗",
   "ai_features": "专利算法过滤翻身、醒来等干扰，自动取得基础体温并判断可孕窗",
   "regulatory": {
    "v": "FDA 企业注册（Tempdrop Ltd.，产品代码 LHD，2019-11 建档），没查到 510(k) 编号",
    "src": "https://beudamed.com/fda_registrations/f55de0c9-4a6a-4291-bb4c-04752112ff6e"
   },
   "price_na": {
    "v": "$219（HSA 商店标价；官网售价页没取到）",
    "date": "2026-11",
    "src": "https://www.hsastore.com/tempdrop-2-advanced-fertility-monitor/41235m.html"
   },
   "north_america": "北美主推（依据：官网美元定价、HSA/FSA 可用、美国经销商 Ovaterra 仅限美国发货）；总部以色列，公司没有明文写北美占比",
   "stage": "在售",
   "total_raised": "没查到外部融资（仅 2014 年 Indiegogo 众筹，未达标）",
   "key_data": [
    {
     "k": "第三方评测发表的验证研究",
     "v": "可孕窗检测准确率 98.6%，排卵日 ±2 天检出 93.3%（194 个周期，公司引用）",
     "date": "2025",
     "src": "https://pubmed.ncbi.nlm.nih.gov/41157380/"
    }
   ],
   "customers": [
    "Ovaterra（美国经销）"
   ],
   "note": "成立年份取官网所说「2014 年众筹起步」，一家聚合站写 2012，没统一。FDA 状态有矛盾：一家第三方站点称「FDA cleared」，另一家称「非 FDA cleared、一般健康类」，只确认到企业注册。融资、估值、收入都没查到。评测文章里的价格区间 $149–199 与 HSA 商店标价不一致，以零售标价为准。"
  },
  {
   "name": "invisaWear",
   "layer": "f10",
   "url": "https://invisawear.com",
   "hq": "洛厄尔（马萨诸塞州）",
   "founded": 2016,
   "product": "invisaWear 安全吊坠 / 项链 / 手链 / 钥匙扣（隐藏按键）",
   "form": "首饰",
   "desc": "首饰里藏按键，双击即向 5 位联系人发位置，可选连 ADT 坐席叫 911",
   "ai_features": "有语音激活求助和 24/7 ADT 真人坐席；没查到自动异常或跌倒检测。",
   "regulatory": {
    "v": "未申请（一般健康类，非医疗器械）",
    "src": "https://invisawear.com/products/beverly-necklace"
   },
   "price_na": {
    "v": "吊坠 Safety Charm $49；Pendant Keychain $64（官网促销价，原价 $99 / $149）；订阅约 $19.99/月（含 24/7 专业监控，商品页写法）",
    "date": "2026-11",
    "src": "https://invisawear.com/collections/all"
   },
   "north_america": "北美公司：官网直销；加拿大与 TELUS 合作（TELUS SmartWear Security）；ADT 监控仅限美国",
   "stage": "在售",
   "revenue": {
    "v": "$600 万",
    "date": "2022",
    "kind": "年销售额，Forbes 报道",
    "src": "https://www.forbes.com/video/6341125910112/this-jewelry-entrepreneur-is-hiding-safety-tech-in-necklaces/"
   },
   "total_raised": "创始人口径：融资约 $300 万；PitchBook 记 $5.3M（聚合站，口径不一致）",
   "funding": [
    {
     "date": "2019-10",
     "round": "种子轮",
     "amount": "金额没查到",
     "lead": "没查到",
     "src": "https://pitchbook.com/profiles/company/181650-34"
    }
   ],
   "key_data": [
    {
     "k": "累计售出（美国）",
     "v": "7 万台以上（上市约 3 年）",
     "date": "2022-11",
     "src": "https://www.forbes.com/sites/katematthams/2022/11/25/how-one-young-entrepreneur-is-using-jewelry-to-keep-women-safe/"
    },
    {
     "k": "累计销售额",
     "v": "超过 $2,000 万（创始人口径）",
     "date": "2025-08",
     "src": "https://www.glcfoundation.org/event/celebrate-giving-2025/"
    }
   ],
   "customers": [
    "ADT",
    "TELUS（加拿大）"
   ],
   "owner": "2023 年创始人 Rajia Abdelaziz 设立控股公司 Smart Alert Holdings，首个收购对象为 Flare（2023-03，金额未披露）",
   "note": "估值没公开。Flare（Flare Jewelry）2023-03 被 Smart Alert Holdings 收购（Lerer Hippeau 领投 $3M 种子轮 2020-02，累计售出 3 万多个手环，来源 https://www.bizjournals.com/boston/inno/stories/news/2023/03/20/smart-bracelet-safety-startup-flare-acquired.html）；getflare.com 现已直接打开 invisaWear 页面，所以 Flare 不单列。成立月份没查到。"
  },
  {
   "name": "ResQ Jewelry",
   "layer": "f10",
   "url": "https://resqjewelry.com",
   "hq": "费城",
   "product": "Shakti Safety Necklace V2（项链，带跌倒检测）及 Maitri 手链",
   "form": "首饰",
   "desc": "首饰式项链，单击发位置和录音，双击连 Noonlight 真人坐席叫 911，带跌倒检测",
   "ai_features": "有跌倒检测（官网称吊坠位置误报更低）；真人坐席而非 AI 响应，没查到 AI 语音或异常检测。",
   "regulatory": {
    "v": "未申请（一般健康类，非医疗器械）",
    "src": "https://resqjewelry.com/pages/fall-detection"
   },
   "north_america": "北美主推：官网 + 亚马逊美国；紧急调度（Noonlight）仅限美国，美国以外只有联系人通知",
   "stage": "在售",
   "key_data": [
    {
     "k": "官网自称",
     "v": "「Trusted by millions across North America」（自称，无依据）",
     "date": "2026-11",
     "src": "https://resqjewelry.com/collections/safety-necklaces-with-fall-detection/products/shakti-safety-necklace-v2-with-fall-detection-gold"
    }
   ],
   "customers": [
    "Noonlight（24/7 监控，2025-12 官宣合作）"
   ],
   "note": "官网自称母女团队、美国设计、独立品牌；2025-12 新闻稿落款为费城（https://investor.wedbush.com/wedbush/article/getnews-2025-12-11-resq-announces-strategic-collaboration-with-noonlight-bringing-advanced-safety-intelligence-to-its-wearable-devices）。成立年份、融资、估值、收入都没查到。美国官网价格没查到（官网页面只写订阅制，未显示美元价）；印度媒体 Siasat 报同名品牌印度起售价 Rs.8,999，是否同一公司没核实。亚马逊上有 Shakti V2 在售。官网 FAQ 写服务为订阅制，订阅价格没查到。"
  },
  {
   "name": "She's Birdie",
   "layer": "f10",
   "url": "https://www.shesbirdie.com",
   "product": "Birdie+（钥匙扣挂件，拔针报警，带 App 与真人坐席）；Birdie 3.0（纯声音版）",
   "form": "首饰",
   "desc": "女性钥匙扣挂件，拔针响 130dB 警报；Birdie+ 另带真人坐席和假来电",
   "ai_features": "没查到 AI 功能：原版 Birdie 是纯声音报警；Birdie+ 只有 App、24/7 真人坐席、假来电和位置分享。",
   "regulatory": {
    "v": "未申请（一般健康类，非医疗器械）",
    "src": "https://www.shesbirdie.com/pages/faqs"
   },
   "price_na": {
    "v": "Birdie+ $39.95（含 3 个月 App 订阅）；Birdie 3.0 $34.95；订阅约 $90/年",
    "date": "2026-02",
    "src": "https://hertripguide.com/reviews/best-personal-safety-alarms-for-women/"
   },
   "north_america": "北美公司：官网直销 + 亚马逊美国/加拿大",
   "stage": "在售",
   "key_data": [
    {
     "k": "官网自称用户",
     "v": "超过 400 万名女性（自称）",
     "date": "2026-11",
     "src": "https://www.shesbirdie.com"
    }
   ],
   "note": "只收挂件：纯声音版 Birdie 属于「没有 AI」的声音报警挂件，按你的规则收录，Birdie+ 有真人坐席。总部城市、成立年份、融资、估值、收入都没查到；官网自述为姐妹创办。Birdie+ 订阅 $90/年 来自 2023 年评测，现价没核（https://www.reviewed.com/health/content/shes-birdie-review）；官网本次打开的价格显示异常（From $279），未采用，Birdie+ 价格取自亚马逊美国页 https://www.amazon.com/-/zh_TW/Shes-Birdie-%E5%A5%B3%E6%80%A7%E6%99%BA%E6%85%A7%E5%80%8B%E4%BA%BA%E5%AE%89%E5%85%A8%E8%AD%A6%E5%A0%B1%E5%99%A8-%E9%9F%BF%E4%BA%AE%E7%9A%84%E8%AD%A6%E5%A0%B1%E5%99%A8%E3%80%81%E9%91%B0%E5%8C%99%E5%9C%88%E3%80%8124-%E5%8D%B3%E6%99%82%E4%BB%A3%E8%A1%A8%E3%80%81%E7%B7%8A%E6%80%A5%E8%AD%A6%E5%A0%B1%E3%80%81%E8%97%8D%E7%89%99%E9%80%A3%E6%8E%A5/dp/B0DBP1YYB9 。"
  },
  {
   "name": "Silent Beacon",
   "layer": "f10",
   "url": "https://silentbeacon.com",
   "hq": "马里兰州",
   "founded": 2013,
   "product": "Silent Beacon 2.0",
   "form": "手环·手表",
   "desc": "蓝牙随身求救按键，可戴手腕或夹衣服，可直拨 911 并双向通话",
   "ai_features": "没查到 AI 功能（官网未提及）。",
   "regulatory": {
    "v": "未申请（一般健康类，非医疗器械）",
    "src": "https://silentbeacon.com/product/silent-beacon-2-0-demo/"
   },
   "price_na": {
    "v": "$59.99；App 付费档 $4.99–$9.99/月（含 24/7 监控）",
    "date": "2026-03",
    "src": "https://silentbeacon.com/product/silent-beacon-2-0-demo/"
   },
   "north_america": "北美公司：官网 + 亚马逊美国；企业客户（医护、社工、市政）为主",
   "stage": "在售",
   "total_raised": "没融资（Tracxn、Owler 聚合站均写未融资）",
   "customers": [
    "居家医护机构",
    "社会服务机构",
    "市政部门",
    "学校（CEO 访谈自述）"
   ],
   "note": "不是女性专属：官网和 CEO 访谈主打职场安全（CEO 自述约 81% 业务为医疗健康），个人版客户评价里有女性用户，作为女性安全硬件的相邻产品收录（它是这一层唯一的手环形态）。总部：Tracxn 写 Germantown，CB Insights 写 Potomac，均在马里兰州，具体城市不一致。成立年份 2013 来自聚合站（https://tracxn.com/d/companies/silent-beacon/__QKl6PWsISnQGtfgvjrKwzWEqGAIhGS4rQV8NPetDc58）。估值、收入没查到。官网价格来自演示商品页，亚马逊美国同价 $59.99。"
  },
  {
   "name": "Clair Health",
   "layer": "f2",
   "url": "https://wearclair.com/",
   "hq": "旧金山",
   "founded": 2025,
   "product": "Clair 激素手环",
   "form": "手环·手表",
   "desc": "手腕十个传感器读体温、HRV 等信号，推算雌激素、孕酮、LH、FSH 趋势",
   "ai_features": "AI 模型在设备端把生理信号推算成激素水平，不直接测激素；公司称周期阶段识别 94% 与每日尿检一致",
   "regulatory": {
    "v": "未申请（先作为健康产品上市，之后再申请 FDA）",
    "src": "https://thenextweb.com/news/clair-health-11-6m-seed-noninvasive-hormone-wearable-khosla-stanford"
   },
   "price_na": {
    "v": "$369 + 订阅 $9.99/月（Pro）或 $5.99/月（Core）；创始会员预购价 $295，含 6 个月订阅",
    "date": "2026-11",
    "src": "https://wearclair.com/checkout"
   },
   "north_america": "北美公司：旧金山；预购限美国，国际版 2027 年",
   "stage": "预售",
   "total_raised": "累计融资约 $11.6M（种子轮；TechCrunch、Fortune、TNW 的跟投名单均未列 Reach Capital）",
   "funding": [
    {
     "date": "2026-06",
     "round": "种子轮",
     "amount": "$11.6M",
     "lead": "Khosla Ventures（a16z speedrun、Brydge Club、Treehub、Cartan Capital、AGI House、Insiders VC、Anne Wojcicki 跟投）",
     "src": "https://techcrunch.com/2026/06/17/two-stanford-grads-raise-11m-to-build-a-noninvasive-wearable-for-hormone-tracking/"
    }
   ],
   "key_data": [
    {
     "k": "候补名单",
     "v": "2.5 万人以上",
     "date": "2026-06",
     "src": "https://fortune.com/2026/06/17/clair-khosla-anne-wojcicki-wearble-oura-whoop-hormone-women-health/"
    },
    {
     "k": "创始会员预购",
     "v": "5,000 个名额（媒体称已售罄）",
     "date": "2026-06",
     "src": "https://www.webpronews.com/stanford-grads-bet-11-6m-seed-on-wristband-that-reads-hormones-without-a-blood-draw/"
    }
   ],
   "customers": [
    "投资人：a16z speedrun、23andMe 联合创始人 Anne Wojcicki"
   ],
   "note": "官网预购页写首批创始会员 2027-01 发货（早前媒体说 2026-11 发货，已推迟），之后普通订单再晚几个月。成立月份没查到（据 TNW 两位创始人 2025 春天在斯坦福认识）。尚无同行评审的验证结果；94% 为公司自报。估值没查到。"
  },
  {
   "name": "EliVive",
   "layer": "f2",
   "url": "https://elivive.com/",
   "hq": "波特兰（缅因州）",
   "product": "汗液激素监测可穿戴（开发中）",
   "form": "贴片",
   "desc": "微流控汗液生物传感，连续追踪女性生殖激素变化",
   "ai_features": "用机器学习解读多次读数，给出个人化激素洞察",
   "regulatory": {
    "v": "未申请（研究阶段）",
    "src": "https://mainestartupsinsider.substack.com/p/sweat-seaweed-and-shellfish"
   },
   "north_america": "北美公司：缅因州波特兰，由当地创业工作室 Ateklo 孵化",
   "stage": "研究",
   "total_raised": "没查到外部融资公告（聚合站 ai-for-clinics 标「A 轮 $20M」，与公司规模不符，一手没证实，未采信）",
   "customers": [
    "Ateklo（孵化）",
    "Babson Seed Fund Pitch Competition 获奖"
   ],
   "note": "2026-02 前后走出隐身状态。成立年份、产品形态细节没查到。一个聚合站标注「A 轮 $20M」，但同页员工只有 2–10 人，与公司自己的信息不匹配，没有一手融资公告，所以没填融资。估值、收入没查到。"
  },
  {
   "name": "Persperity Health",
   "layer": "f2",
   "url": "https://persperityhealth.com/",
   "hq": "洛杉矶",
   "founded": 2024,
   "product": "汗液激素传感器（环状 / 贴片，开发中）",
   "form": "贴片",
   "desc": "用离子导入诱导出汗，测汗液中的雌二醇、孕酮、LH，面向备孕与更年期",
   "ai_features": "没查到 AI 功能（传感器为适配体生物传感，配套 App 输出激素洞察）",
   "regulatory": {
    "v": "未申请（研究阶段）",
    "src": "https://www.femtechworld.co.uk/wellness/persperity-health-raises-1-million-for-sweat-sensing-technology/"
   },
   "north_america": "北美公司：加州，技术授权自 Caltech",
   "stage": "研究",
   "total_raised": "累计融资约 $1M；另有 $3M ARPA-H Spark 拨款（首席研究员在 Caltech）",
   "funding": [
    {
     "date": "2024-11",
     "round": "种子前轮（领投方来自聚合站 Parsers VC）",
     "amount": "$1M",
     "lead": "Freeflow Ventures（Caltech、Wilson Hill Ventures 跟投）",
     "src": "https://www.femtechworld.co.uk/wellness/persperity-health-raises-1-million-for-sweat-sensing-technology/"
    }
   ],
   "customers": [
    "Caltech（技术授权）",
    "ARPA-H"
   ],
   "note": "没有发布日期，也没有价格。成立年份来自 Startuply（2024）。洛杉矶总部来自聚合站。2026-06 Startuply 的文章说传感器已做成贴片，较早报道说是戒指形态，形态以最新为准但官网未核。估值、收入没查到。"
  },
  {
   "name": "Phira（Aurelia Vitals）",
   "layer": "f2",
   "url": "https://www.linkedin.com/company/phirahealth",
   "hq": "休斯顿",
   "founded": 2023,
   "product": "Phira 耳钉后扣",
   "form": "耳戴",
   "desc": "替换耳钉后扣，持续测耳后热调节信号，跟踪雌激素、LH、孕酮的变化规律",
   "ai_features": "用耳后体温和热调节信号，算法找出与三种激素波动一致的周期模式；不直接测激素浓度",
   "regulatory": {
    "v": "没查到 FDA 记录（研究阶段，2027 年商业上市）",
    "src": "https://wellworthy.com/phiras-new-wearable-tracks-hormone-patterns-from-behind-the-ear/"
   },
   "price_na": {
    "v": "没查到（价格未公布，仅开放候补名单）",
    "date": "2026-11",
    "src": "https://wellworthy.com/phiras-new-wearable-tracks-hormone-patterns-from-behind-the-ear/"
   },
   "north_america": "北美公司：美国休斯顿，美国国家科学基金会资助，与莱斯大学、贝勒医学院合作",
   "stage": "研究",
   "total_raised": "没查到外部融资（PitchBook 仅记 $60K 加速器资助，聚合站）",
   "key_data": [
    {
     "k": "试点研究",
     "v": "12 名女性、31 个月经周期，与每日尿检激素对照（IRB 批准）",
     "date": "2026-09",
     "src": "https://wellworthy.com/phiras-new-wearable-tracks-hormone-patterns-from-behind-the-ear/"
    }
   ],
   "customers": [
    "Rice University",
    "Baylor College of Medicine",
    "美国国家科学基金会（拨款）"
   ],
   "note": "2026-09-02 走出隐身状态。成立年份取自创始人 LinkedIn 自述「3 年前起步」，不是登记日期。融资金额、估值、收入都没查到。基础研究论文在 2026-07 的 IEEE EMBC 发表。"
  },
  {
   "name": "Bloomlife",
   "layer": "f3",
   "url": "https://www.bloom-life.com/",
   "hq": "加州（比利时 imec 衍生）",
   "founded": 2015,
   "product": "MFM-Pro 母胎监测贴片",
   "form": "贴片",
   "desc": "腹部贴片，监测母亲与胎儿心率，供高危孕妇在家使用",
   "ai_features": "云端处理腹部电信号，提取母体与胎儿心率；宫缩与完整 NST 适应证待批",
   "regulatory": {
    "v": "FDA 510(k) K222327（MFM-Pro，母体与胎儿心率，2023-02）；宫缩与完整 NST 适应证待批",
    "src": "https://www.510kdatabase.net/k222327/"
   },
   "north_america": "北美公司（加州）；处方设备，经医疗机构提供 Bloomlife Connects 远程监测",
   "stage": "在售",
   "total_raised": "累计融资约 $26M（按本表各轮相加：2016 年前约 $2M + $4M + $8.1M + $12.2M；聚合站说法不一，Caplight 写 $21.55M）",
   "funding": [
    {
     "date": "2016-08",
     "round": "种子轮（无明确领投；参投 Marc Benioff、Efficient Capacity、Kapor Capital、CAA Ventures、Liquid 2 Ventures、MeusInvest、Hanmi IT、The Chernin Group、LanzaTech Ventures、Act One Ventures）",
     "amount": "$4M",
     "src": "https://medcitynews.com/2016/08/bloomfield-life-maps-clinical-pathway-late-term-pregnancy-monitoring/"
    },
    {
     "date": "2017-10",
     "round": "A 轮（聚合站 Crustdata；领投方没查到，聚合站列 Plug and Play Ventures）",
     "amount": "$8.1M",
     "src": "https://crustdata.com/profiles/company/636966"
    },
    {
     "date": "2024-09",
     "round": "A 轮",
     "amount": "$12.2M",
     "lead": "Kapor Capital、Noshaq（RH Capital、15th Rock Ventures、The Grove Foundation、Stardust Equity、Lean Square 跟投）",
     "src": "https://medtechinnovator.org/exclusive-bloomlife-secures-12-2m-series-a-to-advance-remote-maternal-care-platform/"
    }
   ],
   "key_data": [
    {
     "k": "总融资（聚合站）",
     "v": "$24.5M",
     "date": "2026-05",
     "src": "https://yespress.io/eric-dy"
    }
   ],
   "note": "已从消费者宫缩贴片转向处方医疗；消费版是否仍在售没查到。价格、估值、收入没公开。成立年份取自比利时媒体『2015 年 imec 衍生』（https://www.numerikare.be/nl/nieuws/bloomlife-recoit-le-feu-vert-de-la-fda-pour-son-tracker-de-grossesse.html）。2024-01 FDA 新闻：https://www.femtechworld.co.uk/news/fda-clears-innovative-maternal-and-foetal-monitoring-device/"
  },
  {
   "name": "Marani Health",
   "layer": "f3",
   "url": "https://www.maranihealth.com/",
   "hq": "明尼苏达州奥克代尔",
   "founded": 2018,
   "product": "M·care 系统 / M·wrap 孕期腹带",
   "form": "系统",
   "desc": "腹带电极采集胎儿与母亲心电，在家完成处方孕期监测",
   "ai_features": "官方称 AI 驱动软件平台与早期风险识别；具体算法没公开",
   "regulatory": {
    "v": "FDA 510(k)（M·care 系统 MW-20，含 M·wrap，2026-09）；K 号没查到",
    "src": "https://www.medicaldevice-network.com/news/fda-clears-marani-health-maternal-remote-monitoring-system/"
   },
   "north_america": "北美公司；计划 2027 年向美国健康系统和保险公司商业化",
   "stage": "预售",
   "total_raised": "累计融资约 $17.4M（PitchBook，聚合站；Tracxn 写 $13.6M，两者不一致）",
   "funding": [
    {
     "date": "2021-02",
     "round": "种子轮",
     "amount": "$3.7M",
     "lead": "SWL Healthcare Ventures（TFX Capital 跟投）",
     "src": "https://www.bizjournals.com/twincities/inno/stories/fundings/2021/02/25/pregnancy-care-startup-marani-health-raises.html"
    },
    {
     "date": "2021-11",
     "round": "种子轮",
     "amount": "$7.6M",
     "lead": "OneAlphaNorth Capital（SWL Healthcare Ventures、TFX Capital 跟投）",
     "src": "https://www.bizjournals.com/twincities/inno/stories/fundings/2021/11/16/marani-health-seed-round-76-million.html"
    },
    {
     "date": "2025-04",
     "round": "新一轮（金额未披露）",
     "amount": "未披露",
     "lead": "Tidal River Fund",
     "src": "https://www.linkedin.com/posts/galia-gichon_tidal-river-fund-is-excited-to-announce-a-activity-7315446699185889280-PU6W"
    }
   ],
   "key_data": [
    {
     "k": "计划商业化",
     "v": "2027 年",
     "date": "2026-09",
     "src": "https://www.medicaldevice-network.com/news/fda-clears-marani-health-maternal-remote-monitoring-system/"
    }
   ],
   "customers": [
    "Mayo Clinic（合作）"
   ],
   "note": "2026-09 获批，官方称 2027 年商业发布，故 stage 记预售。价格、估值、收入没公开。成立年份取自 PitchBook、Tracxn 聚合站。融资聚合站：https://pitchbook.com:8443/profiles/company/279088-48"
  },
  {
   "name": "Nuvo INVU",
   "layer": "f3",
   "url": "https://www.nuvocares.com/",
   "hq": "佛罗里达州阿文图拉（研发源自以色列）",
   "product": "INVU 孕期监测腰带",
   "form": "系统",
   "desc": "孕妇在家自测胎心、母心与宫缩，做居家无应激试验",
   "ai_features": "没查到公开的算法细节；2026-01 发布含胎儿/母体心电的 AI-ready 孕期数据集",
   "regulatory": {
    "v": "FDA 510(k) K210025 与 K221046（官网称自 2020 年共 3 项 510(k)；适用 32 周起居家自测 NST）",
    "src": "https://www.nuvocares.com/invest"
   },
   "north_america": "北美公司；美国与以色列医院和妇产诊所，按处方租用",
   "stage": "在售",
   "valuation": {
    "v": "$269M",
    "date": "2023-12",
    "kind": "SPAC 合并前股权估值（最高约 $300M），公司公告",
    "src": "https://www.spacinsider.com/news/deal-announcements-amendments/lamf-global-ventures-corp-i-signs-loi-with-nuvo-group"
   },
   "total_raised": "累计融资没查到公司口径（CB Insights 聚合写 $68M）；LAMF SPAC 已于 2024-05-01 交割，2024-11 起进入美国破产程序，2024-12 资产被 Kips Bay Select LP 资助的 Nuvo Int'l 收购",
   "funding": [
    {
     "date": "2022",
     "round": "可转债（2022–2023 累计，出借方未具名）",
     "amount": "$7.9M",
     "src": "https://www.cstproxy.com/lamfglobal/2024/2024-04-01/proxy/images/LAMF_Global_Ventures_Corp_I-EGMProxy2024.pdf"
    },
    {
     "date": "2023",
     "round": "过桥融资（Interim Financing，投资方未具名）",
     "amount": "约 $13M",
     "src": "https://www.cstproxy.com/lamfglobal/2024/2024-04-01/proxy/images/LAMF_Global_Ventures_Corp_I-EGMProxy2024.pdf"
    },
    {
     "date": "2024-05",
     "round": "SPAC 合并上市（LAMF Global Ventures Corp. I，已交割，Nasdaq: NUVO；募资额没查到）",
     "amount": "未披露",
     "lead": "LAMF Global Ventures",
     "post": "合并前股权估值 $269M（达里程碑后最高约 $300M）",
     "src": "https://www.nasdaq.com/press-release/remote-pregnancy-care-innovator-nuvo-group-ltd.-becomes-public-company-through"
    }
   ],
   "key_data": [
    {
     "k": "累计居家监测",
     "v": "2.5 万+ 次，45 万+ 分钟",
     "date": "2026-10",
     "src": "https://www.nuvocares.com/invest"
    }
   ],
   "customers": [
    "The Pregnancy Care Group",
    "TLC Perinatal"
   ],
   "owner": "2024-05 经 LAMF SPAC 在纳斯达克上市（NUVO）；2024-11 进入美国破产程序，2024-12 资产被 Kips Bay Select LP 资助的 Nuvo Int'l 收购（金额未披露）",
   "note": "腰带式传感带，form 取「系统」。2026-02 起可经医生按周/月租用（处方），价格官网没公开（https://www.nuvocares.com/newsroom/invu-wearable-pregnancy-monitoring-at-home-or-work）。2023-08 宣布与 LAMF SPAC 合并上市（https://www.nasdaq.com/press-release/nuvo-group-ltd.-an-fda-cleared-leading-innovator-in-pregnancy-care-to-become-a-public），是否交割、融资总额、估值、收入没查到可靠一手数字。成立年份没查到。"
  },
  {
   "name": "Raydiant Oximetry",
   "layer": "f3",
   "url": "https://www.raydiantoximetry.com/",
   "hq": "加州圣拉蒙",
   "product": "Lumerah 经腹胎儿脉搏血氧",
   "form": "贴片",
   "desc": "分娩时无创测量胎儿血氧，更早发现胎儿窘迫",
   "ai_features": "没查到 AI 功能（临床数据用于优化血氧算法，在研）",
   "regulatory": {
    "v": "未上市；FDA IDE 早期可行性研究已获批（2024-04），获突破性器械认定",
    "src": "https://www.globenewswire.com/news-release/2024/04/10/2860975/0/en/Raydiant-Oximetry-Secures-FDA-Approval-for-Lumerah-Investigational-Device-Exemption-IDE-Study.html"
   },
   "north_america": "北美公司；美国 IDE 临床研究",
   "stage": "临床",
   "funding": [
    {
     "date": "2024-06",
     "round": "A3 延长轮",
     "amount": "$7.5M",
     "lead": "Cross-Border Impact Ventures（RH Capital、Global Health Impact Fund、VCapital、March of Dimes 跟投）",
     "src": "https://www.fogartyinnovation.org/raydiant-oximetry-oversubscribes-series-a3-funding-round-to-support-clinical-studies/"
    }
   ],
   "key_data": [
    {
     "k": "盖茨基金会拨款",
     "v": "$1M",
     "date": "2024-09",
     "src": "https://medtechinnovator.org/cohortnews/raydiant-oximetry-secures-1-million-grant-to-advance-fetal-monitoring-technology/"
    }
   ],
   "note": "创始人 Neil Ray（小儿麻醉医生）。成立年份、累计融资、估值没查到。早期临床用经阴道传感器采集数据，经腹传感器为目标产品。"
  },
  {
   "name": "Sibel Health ANNE Maternal",
   "layer": "f3",
   "url": "https://sibelhealth.com/",
   "hq": "伊利诺伊州尼尔斯（芝加哥地区）",
   "product": "ANNE Maternal / ANNE One 柔性皮肤贴片",
   "form": "贴片",
   "desc": "全无线贴片，产房与产后连续监测产妇生命体征和胎心",
   "ai_features": "内置改良产科早期预警评分（MEOWS）决策支持；盖茨基金会另拨 $5M 开发 AI 功能与低成本版",
   "regulatory": {
    "v": "FDA 510(k) K253021（ANNE Maternal，2026-02-26）；ANNE One 另有 510(k)",
    "src": "https://www.510kdatabase.net/k253021/"
   },
   "north_america": "北美公司；美国医院，医保/Medicaid/Medicare 覆盖符合条件患者",
   "stage": "在售",
   "total_raised": "累计融资约 $80M+（2022-08 公司口径超 $50M + 2025-03 C 轮 $30M，本表相加）；另获盖茨基金会 $17.5M 拨款（2024-04）",
   "funding": [
    {
     "date": "2020",
     "round": "A 轮",
     "amount": "$10M",
     "lead": "Dräger",
     "src": "https://medtechinnovator.org/cohortnews/sibel-health-announces-close-of-new-series-c-financing-and-new-fda-510k-clearance/"
    },
    {
     "date": "2022-08",
     "round": "B 轮",
     "amount": "$33M",
     "lead": "Steele Foundation for Hope（Dräger 将可转债转为股权）",
     "src": "https://www.finsmes.com/2022/08/sibel-health-raises-33m-in-series-b-funding.html"
    },
    {
     "date": "2025-03",
     "round": "C 轮",
     "amount": "$30M",
     "lead": "Steele Foundation for Hope、Dräger",
     "src": "https://www.mobihealthnews.com/news/sibel-health-secures-30m-seventh-fda-clearance"
    }
   ],
   "key_data": [
    {
     "k": "盖茨基金会拨款",
     "v": "$17.5M",
     "date": "2024-04",
     "src": "http://www.femtechworld.co.uk/news/start-up-awarded-us17-5m-grant-to-advance-maternal-monitoring-technology-for-low-and-middle-income-countries/"
    }
   ],
   "customers": [
    "University of Edinburgh（研究合作）",
    "Dräger（战略伙伴）",
    "盖茨基金会"
   ],
   "note": "产品面向医院与低收入国家，非消费者购买；价格没公开。成立年份、估值、收入没查到。新闻稿 2026-04-09：https://medtechinnovator.org/cohortnews/sibel-health-receives-fda-clearance-for-anne-maternal-a-comprehensive-and-fully-wireless-maternal-fetal-monitoring-platform/"
  },
  {
   "name": "Elvie（Willow）",
   "layer": "f4",
   "url": "https://www.elvie.com/",
   "hq": "伦敦",
   "founded": 2013,
   "product": "Elvie Pump / Elvie Stride 2",
   "form": "吸奶罩",
   "desc": "静音入胸衣吸奶器，奶直接进防漏袋",
   "ai_features": "App 记录吸奶量；没查到 AI 功能",
   "regulatory": {
    "v": "FDA 510(k) K181863（Elvie Pump，2018-10）；Elvie Stride 2 K242125（2024）",
    "src": "https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K181863"
   },
   "north_america": "英国品牌，2025-03 起归美国 Willow；510(k) 申请人为英国 Chiaro Technology",
   "stage": "在售",
   "valuation": {
    "v": "约 $241M",
    "date": "2025-03",
    "kind": "聚合站（Seedtable）",
    "src": "https://seedtable.com/exits/elvie"
   },
   "total_raised": "累计融资超 $186M（聚合站 Seedtable；Tracxn 写 $158M，口径不一）",
   "funding": [
    {
     "date": "2014-05",
     "round": "种子轮（聚合站 Dealroom，一手没查到）",
     "amount": "$1.2M",
     "lead": "NJF Capital",
     "src": "https://biobase.whitefordresearch.com/companies/elvie"
    },
    {
     "date": "2017-03",
     "round": "A 轮",
     "amount": "$6M",
     "lead": "Octopus Ventures（AllBright 跟投）",
     "src": "https://techcrunch.com/2017/03/22/elvie-pulls-in-6m-series-a-to-build-a-global-female-health-tech-brand/"
    },
    {
     "date": "2019-04",
     "round": "B 轮",
     "amount": "$42M",
     "lead": "IPGL（Octopus Ventures、Impact Ventures UK 跟投）",
     "src": "https://techcrunch.com/2019/04/02/elvie-raises-42m-to-become-the-go-to-destination-for-womens-health/"
    },
    {
     "date": "2021-07",
     "round": "C 轮",
     "amount": "$80M（£58M）",
     "lead": "BGF（BlackRock Private Equity Partners、Hiro Capital、Westerly Winds、Octopus Ventures、IPGL 跟投）",
     "src": "https://www.businesswire.com/news/home/20210727005714/en/"
    },
    {
     "date": "2021-09",
     "round": "C 轮追加（无单一领投；参投 Blume Equity 联合创始人旗下基金、IPGL、Hiro Capital、Westerly Winds）",
     "amount": "$17.5M（£12.7M）",
     "src": "https://techcrunch.com/2021/09/07/womens-health-tech-brand-elvie-tops-up-series-c-to-97m/"
    },
    {
     "date": "2022",
     "round": "老股东内部轮（聚合站 Dealroom/Sifted）",
     "amount": "£18.5M",
     "src": "https://biobase.whitefordresearch.com/companies/elvie"
    },
    {
     "date": "2024-04",
     "round": "老股东追加（聚合站 Dealroom/Sifted）",
     "amount": "£9.6M",
     "src": "https://biobase.whitefordresearch.com/companies/elvie"
    }
   ],
   "owner": "2025-03 被 Willow 收购（Elvie 进入破产管理后，管理人 FTI Consulting 将业务资产出售给 Willow 旗下子公司，金额未披露）",
   "note": "倒闭后被 Willow 收购，非独立运营。当前北美官网售价没核到，不入 price。Elvie 另有盆底训练器，见 Elvie Trainer（Willow）。Stride 2 FDA 记录：https://www.accessdata.fda.gov/cdrh_docs/pdf24/K242125.pdf"
  },
  {
   "name": "eufy S1 Pro（Anker）",
   "layer": "f4",
   "url": "https://www.eufy.com/",
   "hq": "深圳（母公司 Anker）",
   "founded": 2025,
   "product": "eufy S1 Pro 带热敷穿戴吸奶器",
   "form": "吸奶罩",
   "desc": "带 95–105°F 热敷、促进泌乳的穿戴吸奶器",
   "ai_features": "App 优化吸乳节奏；没查到 AI 功能",
   "regulatory": {
    "v": "FDA 510(k) 声称有，K 号没查到（只见中文公众号转述，待核）",
    "src": "https://www.macys.com/shop/product/eufy-security-eufy-s1-pro-wearable-breast-pump-with-heatflow-technology?ID=21424145"
   },
   "price_na": {
    "v": "标价 $349.99，Macy's 促销价 $259.99",
    "date": "2026",
    "src": "https://www.macys.com/shop/product/eufy-security-eufy-s1-pro-wearable-breast-pump-with-heatflow-technology?ID=21424145"
   },
   "north_america": "北美主推渠道：亚马逊美国、Macy's、Anker 官网",
   "stage": "在售",
   "product_line_of": "Anker",
   "note": "首发年 2025 取自公众号『2025 年全球销售』，英文一手出处没查到。融资不适用，pub 未核。"
  },
  {
   "name": "Legendairy Milk Imani i2",
   "layer": "f4",
   "url": "https://www.legendairymilk.com/",
   "product": "Imani i2 / i2 Plus 穿戴吸奶器",
   "form": "吸奶罩",
   "desc": "无 App 极简穿戴吸奶器，价格约为头部款三分之一",
   "ai_features": "没查到 AI 功能；无屏幕无 App",
   "regulatory": {
    "v": "FDA 510(k) K202037（imani i2，2021-03-01，申请人 Imani Co.）；i2 Plus K222573",
    "src": "https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K202037"
   },
   "north_america": "北美主推：Legendairy Milk 为美国分销商，亚马逊与官网；Imani 为设备制造商",
   "stage": "在售",
   "total_raised": "没查到外部融资（创始人 Luna Aziz 在 2026-02 播客中自述无投资人）",
   "note": "Wired 2023 评测称设备由 Imani 制造、Legendairy 在美分销（https://www.wired.com/review/imani-i2/）。作为平价款保留，因为有 FDA 记录且被媒体评测。总部、成立年份、融资、当前价格没查到。"
  },
  {
   "name": "Medela Freestyle Hands-free",
   "layer": "f4",
   "url": "https://www.medelabreastfeedingus.com/",
   "hq": "瑞士楚格（美国总部伊利诺伊州）",
   "founded": 2022,
   "product": "Freestyle Hands-free 穿戴吸奶器",
   "form": "吸奶罩",
   "desc": "泵机放口袋、集乳杯放胸衣内的穿戴吸奶器",
   "ai_features": "连接 Medela Family App；没查到 AI 功能",
   "regulatory": {
    "v": "FDA 510(k)（Freestyle Hands-free）；K 号没查到，只确认经销商称 FDA 许可",
    "src": "https://healthcaredme.com/product/freestyle-hands-free-breast-pump/?add-to-cart=44722"
   },
   "price_na": {
    "v": "$349.99（经销商）",
    "date": "2025-12",
    "src": "https://healthcaredme.com/product/freestyle-hands-free-breast-pump/?add-to-cart=44722"
   },
   "north_america": "北美主推之一：亚马逊、医疗器械经销商与保险渠道",
   "stage": "在售",
   "key_data": [
    {
     "k": "亚马逊加拿大首次上架",
     "v": "2022-12-02",
     "date": "2022-12",
     "src": "https://www.amazon.ca/gp/aw/d/B0BNW6Q1CY/"
    }
   ],
   "product_line_of": "Medela",
   "note": "founded 取亚马逊加拿大『首次上架 2022-12』作为该产品首发年的近似。母公司 Medela 为瑞士私营公司，pub 未核。融资不适用。"
  },
  {
   "name": "Momcozy",
   "layer": "f4",
   "url": "https://momcozy.com/",
   "hq": "深圳",
   "founded": 2017,
   "product": "Momcozy M5 / M9 穿戴吸奶器",
   "form": "吸奶罩",
   "desc": "中端价位的穿戴吸奶器，亚马逊美国走量",
   "ai_features": "M9 带 App 控制；没查到 AI 功能",
   "regulatory": {
    "v": "FDA 510(k) K253934（Momcozy Wearable Breast Pump BP380/M5 系列，2026-03-09，申请人 Shenzhen Root Innovation Technology）",
    "src": "https://www.510kdatabase.net/k253934/"
   },
   "price_na": {
    "v": "M5 2 只装 $199.99（亚马逊美国，价格追踪站）",
    "date": "2026-10",
    "src": "https://www.sellersnooper.com/Momcozy%20Official%20Store/productsByRevenue"
   },
   "north_america": "北美主推：亚马逊美国为主渠道",
   "stage": "在售",
   "total_raised": "外部融资仅见 2023-12 一笔战略投资，金额未披露",
   "funding": [
    {
     "date": "2023-12",
     "round": "战略投资（一手只见 EqualOcean 报道；公众号称「数千万人民币」，未证实）",
     "amount": "未披露",
     "lead": "Hainan Xiaohujing Private Equity Fund（海南小虎鲸私募股权投资基金）",
     "src": "https://equalocean.com/news/2023121820396-chinese-maternal-infant-brand-momcozy-secured-backup-investment-firm-xiaohujing"
    }
   ],
   "note": "年收入、市占率的数字目前只见于中文公众号，英文一手出处没查到，故不写入 rev。融资没查到。成立年份 2017 同样只见公众号，待核。"
  },
  {
   "name": "Willow",
   "layer": "f4",
   "url": "https://www.onewillow.com/",
   "hq": "加州山景城",
   "founded": 2014,
   "product": "Willow 3.0 / Willow Go 入胸衣穿戴吸奶器",
   "form": "吸奶罩",
   "desc": "完全放进胸衣的无线吸奶器，开会走路也能吸奶",
   "ai_features": "App 控制吸力与记录；没查到 AI 功能",
   "regulatory": {
    "v": "FDA 510(k) K191577（Willow Wearable Breast Pump 2.0，2019-09，OTC）；3.0、Go 的 K 号没逐一核",
    "src": "https://www.accessdata.fda.gov/cdrh_docs/pdf19/K191577.pdf"
   },
   "price_na": {
    "v": "Willow Go 首发价 $329，保险下低至 $150（2022-03 首发价，当前官网价没核到）",
    "date": "2022-03",
    "src": "https://femtechinsider.com/willow-go-launch/"
   },
   "north_america": "北美公司；Target 等零售 + 保险报销 + HSA/FSA",
   "stage": "在售",
   "total_raised": "累计融资约 $166M（聚合/媒体，说法不一；Tracxn 写 $228M，PitchBook 写 $234M，含 2024-01 一笔聚合站数据，一手没证实）",
   "funding": [
    {
     "date": "2015-01",
     "round": "A 轮（聚合站 Multiples；参投 ExploraMed、New Enterprise Associates、Johnson & Johnson Innovation，领投方没查到）",
     "amount": "$15M",
     "src": "https://multiples.vc/private-comps/willow"
    },
    {
     "date": "2019-12",
     "round": "未标轮次（Mercom 称 NEA、Meritech 共同领投）",
     "amount": "$20M",
     "lead": "New Enterprise Associates、Meritech Capital Partners",
     "post": "累计 $100M",
     "src": "https://mercomcapital.com/tag/meritech-capital-partners/"
    },
    {
     "date": "2020-09",
     "round": "C 轮",
     "amount": "$55M",
     "lead": "New Enterprise Associates、Meritech Capital Partners、Lightstone Ventures（Perceptive Advisors 跟投）",
     "post": "累计 $155M",
     "src": "https://mercomcapital.com/willow-raises-55-million-for-smart-wearable-breast-pump/"
    },
    {
     "date": "2021-04",
     "round": "C 轮延长",
     "amount": "$26.8M",
     "lead": "Endeavour Vision（New Enterprise Associates、Pura Vida Investments、Purple Arch Ventures、Logos Capital、Gaingels 跟投）",
     "post": "C 轮合计 $81.8M",
     "src": "https://mercomcapital.com/willow-raises-26-8-million-in-series-c-funding-round/"
    }
   ],
   "customers": [
    "Target",
    "保险报销渠道"
   ],
   "note": "2025-03 收购 Elvie；2026-10-27 宣布收购 Swehl（哺乳教育）与 Momtech（Mōmi 奶瓶），新任 CEO Carolin Archibald，金额均未披露（Business Wire：https://www.fidelity.com/news/article/mergers-and-acquisitions/202610270900BIZWIRE_USPR_____20261027_BW277506 ；Fast Company：https://www.fastcompany.com/91629943/willow-wearable-breast-pump-acquisition）。估值、收入没公开。累计融资聚合：https://yespress.io/willow-innovations-inc"
  },
  {
   "name": "Zomee Fit",
   "layer": "f4",
   "url": "https://zomee.com/",
   "hq": "佛罗里达州庞帕诺比奇",
   "founded": 2020,
   "product": "Zomee Fit 穿戴吸奶器",
   "form": "吸奶罩",
   "desc": "入胸衣无外置电机，带倒乳头矫正模式的平价穿戴吸奶器",
   "ai_features": "没查到 AI 功能，且不依赖 App",
   "regulatory": {
    "v": "没查到 Zomee Fit 的 FDA 510(k) K 号；官网称医院级，保险覆盖",
    "src": "https://zomee.com/es/collections/breast-pumps-1"
   },
   "north_america": "北美公司；保险覆盖 + 医疗耗材经销商（Edgepark 等）",
   "stage": "在售",
   "total_raised": "没查到外部融资",
   "note": "创始人 Dina Shanowitz；2026-04 入选 USA Today『家长最信任品牌』（https://www.globenewswire.com/fr/news-release/2026/04/17/3276424/0/en/Zomee-Named-One-of-USA-TODAY-s-Most-Trusted-Brands-by-Parents-in-2026.html）。成立年份取自 LinkedIn 页的 2020，待核；Edgepark 页写制造商为 ZEV SUPPLIES CORP dba Zomee（https://my.edgepark.com/breast-pumps/breast-pumps-and-supplies/breast-pumps-/zomee-fit-hands-free-wearable-breast-pump/p/unmzfhf）。价格、融资没查到。"
  },
  {
   "name": "Axena Health Leva",
   "layer": "f5",
   "url": "https://www.axenahealth.com/",
   "hq": "马萨诸塞州牛顿",
   "founded": 2023,
   "founded_month": "2023-02",
   "product": "leva Pelvic Health System",
   "form": "体内",
   "desc": "阴道内运动传感器配 App，居家治疗压力性与混合性尿失禁",
   "ai_features": "App 实时可视化骨盆运动并引导训练；没查到 AI 功能",
   "regulatory": {
    "v": "FDA 510(k) K213913（leva Pelvic Health System，2022-06-30，Renovia 持有；Axena 收购）",
    "src": "https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K213913"
   },
   "north_america": "北美公司；处方医疗器械",
   "stage": "在售",
   "total_raised": "Axena 累计融资约 $34.4M（A 轮 $25M + $9.4M；AXA IM Alts 领英称 A 轮合计近 $31M，口径不一）；前身 Renovia 此前融资不计入",
   "funding": [
    {
     "date": "2023-02",
     "round": "A 轮",
     "amount": "$25M",
     "lead": "AXA IM Alts（KOFA Healthcare、Avestria Ventures 跟投）",
     "src": "https://www.businesswire.com/news/home/20230216005576/en/Axena-Health-Secures-%2425M-Series-A-Investment-to-Accelerate-Global-Adoption-of-Digital-Health-Treatment-for-Female-Incontinence"
    },
    {
     "date": "2024-06",
     "round": "A 轮最后一笔",
     "amount": "$9.4M",
     "lead": "AXA IM Alts（Cross-Border Impact Ventures、KOFA Healthcare、Avestria Ventures 跟投）",
     "src": "https://finance.yahoo.com/news/axena-health-closes-over-9-120000150.html"
    }
   ],
   "note": "价格、估值、收入没公开。Renovia 此前融资（B 轮 $32.3M、C-1 轮 $17M）来自 MobiHealthNews：https://www.mobihealthnews.com/news/axena-health-raises-25m-support-pelvic-floor-digital-therapeutic 2023-02 Axena 用 A 轮资金收购了 Renovia（leva 原厂，2022 年停业）几乎全部资产；Axena 本身是独立公司。"
  },
  {
   "name": "Elidah Elitone",
   "layer": "f5",
   "url": "https://elitone.com/",
   "hq": "康涅狄格州牛顿",
   "founded": 2014,
   "product": "Elitone / Elitone URGE",
   "form": "贴片",
   "desc": "贴在会阴的外用电刺激，穿衣服下治疗尿失禁",
   "ai_features": "没查到 AI 功能",
   "regulatory": {
    "v": "FDA 510(k)（Elitone 女性压力性、URGE 急迫性已获批；Elitone for Men 2026-03-31 获批）；K 号没查到",
    "src": "https://elitone.com/wp-content/uploads/2026/03/Elitone-for-Men-Press-Release-033126.pdf"
   },
   "north_america": "北美公司；官网直营，医保覆盖（HCPCS E0740）需处方",
   "stage": "在售",
   "total_raised": "没查到外部融资（CB Insights 标 A 轮，金额与投资方没有一手出处）",
   "note": "外用、贴会阴、无需探头，是少数真穿戴的盆底方案；创始人 Gloria 与 Eric Kolb（https://elitone.com/press-kit/）。融资没查到可靠数字（CB Insights 标 A 轮）；价格只在聚合站见到 $399，不入 price。"
  },
  {
   "name": "Elvie Trainer（Willow）",
   "layer": "f5",
   "url": "https://www.elvie.com/",
   "hq": "伦敦",
   "founded": 2017,
   "product": "Elvie Trainer",
   "form": "体内",
   "desc": "体内感应器配 App 的凯格尔训练器，实时显示盆底收缩",
   "ai_features": "App 实时纠正动作；没查到 AI 功能",
   "regulatory": {
    "v": "没查到 510(k) 记录；经销商称 FDA registered（登记，非 510(k)）",
    "src": "https://lady-comp.com/ch/en/shop/products/elvie-kegel-trainer/"
   },
   "price_na": {
    "v": "$199（经销商 myPFM）",
    "date": "2026",
    "src": "https://www.mypfm.com/shop-health-and-fitness/elvie-trainer"
   },
   "north_america": "英国品牌，现归美国 Willow；北美经销商和官网",
   "stage": "在售",
   "owner": "2025-03 随 Elvie 业务被 Willow 收购（金额未披露）",
   "note": "founded 取该产品 2017 年发布（经销商文案称入选 2017 奥斯卡提名者礼包）；精确首发月份没查到。融资见 Elvie（Willow）。"
  },
  {
   "name": "Joylux vFit",
   "layer": "f5",
   "url": "https://joylux.com/",
   "hq": "西雅图",
   "founded": 2014,
   "product": "vFit Gold PLUS",
   "form": "体内",
   "desc": "红光、热与声波的阴道内设备，用于盆底与亲密健康",
   "ai_features": "没查到 AI 功能",
   "regulatory": {
    "v": "未申请（一般健康类）：被 FDA 列为低风险一般健康设备",
    "src": "https://meridianmedseattle.squarespace.com/services/v-fit-joylux"
   },
   "north_america": "北美公司；美国医生诊所与线上零售",
   "stage": "在售",
   "total_raised": "累计融资超 $20M（GeekWire 2022-11 转述公司口径；A 轮合计 $13M）",
   "funding": [
    {
     "date": "2018-01",
     "round": "A 轮（无明确领投；参投 Rick Segal、Alliance of Angels、Houston Angel Network、Belle Capital、Golden Seeds）",
     "amount": "$5M",
     "src": "https://www.finsmes.com/2018/01/joylux-secures-5m-in-series-a-funding.html"
    },
    {
     "date": "2019-05",
     "round": "A 轮追加（无明确领投；参投 Alliance of Angels、Belle Capital、Portfolia、Sofia Fund、Kimberly-Clark）",
     "amount": "$7M",
     "src": "https://www.geekwire.com/2019/womens-sexual-health-startup-joylux-raises-more-cash-lands-in-gwyneth-paltrows-goop-store/"
    },
    {
     "date": "2022-11",
     "round": "A 轮追加",
     "amount": "$5.5M",
     "lead": "J-Ventures、J-Impact（Kathy Fields 跟投）",
     "src": "https://www.geekwire.com/2022/seattle-startup-joylux-which-sell-devices-for-menopausal-women-raises-more-cash/"
    }
   ],
   "note": "更偏更年期与亲密健康，疑似分组应放 f6，请复核。2026 年另有红光痛感穿戴 Ilyeo body（https://www.cbinsights.com/company/isis-labs）。成立年份取自 CB Insights。估值、收入、价格没查到。"
  },
  {
   "name": "Pelvital Flyte",
   "layer": "f5",
   "url": "https://www.flytetherapy.com/",
   "hq": "明尼苏达州伊根",
   "founded": 2016,
   "product": "Flyte System",
   "form": "体内",
   "desc": "阴道内振动阻力棒，在凯格尔时加强盆底治疗压力性尿失禁",
   "ai_features": "棒内加速度与陀螺仪给出视觉反馈；没查到 AI 功能",
   "regulatory": {
    "v": "FDA 510(k) K212655（Flyte System）；Special 510(k) K233362（2023-12 标签修改）",
    "src": "https://www.accessdata.fda.gov/cdrh_docs/pdf23/K233362.pdf"
   },
   "north_america": "北美公司；诊所推广并争取保险覆盖",
   "stage": "在售",
   "total_raised": "累计融资约 $10M（聚合站 Caplight）",
   "funding": [
    {
     "date": "2023-08",
     "round": "种子轮",
     "amount": "$2.6M+",
     "lead": "Boomerang Ventures",
     "src": "https://bdmtglobal.com/wp-content/uploads/2023/08/e-times-15-2023.pdf"
    }
   ],
   "note": "棒体与手持控制器有线相连，严格说不算无线穿戴，范围边缘。价格、估值、收入没查到。成立年份取自 Caplight。聚合站：https://www.caplight.com/company/flytetherapy"
  },
  {
   "name": "Perifit",
   "layer": "f5",
   "url": "https://perifit.co/",
   "hq": "巴黎",
   "founded": 2016,
   "product": "Perifit Care / Care+",
   "form": "体内",
   "desc": "游戏化的阴道内盆底训练探头，治疗尿失禁",
   "ai_features": "没查到 AI 功能；以游戏化生物反馈为主",
   "regulatory": {
    "v": "FDA 510(k) K221476（Perifit）；K231780（Perifit Care+，2023-2024）",
    "src": "https://www.accessdata.fda.gov/cdrh_docs/pdf23/K231780.pdf"
   },
   "price_na": {
    "v": "Perifit Care $149 / Care+ $179（授权零售商 Vagercise 页）",
    "date": "2026",
    "src": "https://vagercise.com/blogs/whats-up-down-there/perifit-care-vs-perifit-care-kegel-trainer-comparison"
   },
   "north_america": "北美主推：美国授权零售商与官网；2024 年 Care+ 在美推出",
   "stage": "在售",
   "total_raised": "没查到外部融资（法国媒体称无融资；2017 年产品众筹约 $400K，Crustdata 聚合）",
   "note": "公司 X6 Innovations SAS，CEO Cyril Haoudi（El Nacional 2026-01：https://www.elnacional.cat/oneconomia/es/empresas/perifit-negocio-millonario-permite-entrenar-pelvis-con-sonda_1545268_102.html）。成立年份：ACM 论文称 2016，Crustdata 写 2017，不一致，取 2016。聚合站：https://crustdata.com/profiles/company/perifit 。估值、收入没查到。"
  },
  {
   "name": "Yarlap",
   "layer": "f5",
   "url": "https://www.amazon.com/dp/B01N7K06HW",
   "product": "Yarlap（带 AutoKegel 电刺激）",
   "form": "体内",
   "desc": "电刺激与六套训练程序的阴道探头，改善压力性尿失禁",
   "ai_features": "没查到 AI 功能",
   "regulatory": {
    "v": "FDA 510(k) K160773（Yarlap II，2016-05；其后版本未逐一核）",
    "src": "https://fda.innolitics.com/submissions/GU/subpart-f-therapeutic-devices/KPI/K160773"
   },
   "north_america": "北美主推：亚马逊美国，HSA/FSA 可用；美国设计英国制造",
   "stage": "在售",
   "total_raised": "没查到外部融资（PitchBook 记 2016 年天使轮、2024-10 二级转让，金额与投资方未披露，聚合站）",
   "note": "资料很少：公司总部、成立年份、融资、当前价格都没查到，官网链接也没核到，url 暂放亚马逊商品页。属电刺激而非传感类，勉强算可穿戴，范围边缘。"
  },
  {
   "name": "Amira Health",
   "layer": "f6",
   "url": "https://apps.apple.com/us/app/amira-terra/id6456942647",
   "hq": "旧金山",
   "founded": 2020,
   "product": "Terra System（传感手环 + 降温床垫垫）",
   "form": "系统",
   "desc": "手环预判夜间潮热，床垫垫提前冷却，帮女性睡整觉",
   "ai_features": "手环监测皮肤微量汗液等信号，机器学习在潮热发作前预测并触发冷却（云端算法）",
   "regulatory": {
    "v": "没查到 FDA 记录（NIH SBIR 在资助验证，2025）",
    "src": "https://www.sbir.gov/awards/219280"
   },
   "price_na": {
    "v": "$699（2024-01 CES 发布价，预购 75 折）；现价没核到",
    "date": "2024-01",
    "src": "https://medcitynews.com/2024/01/menopause-startup-launches-ai-powered-hot-flash-care-product/"
   },
   "north_america": "北美公司：官网直销（App 仅 iOS/Android 美国商店）",
   "stage": "在售",
   "total_raised": "累计融资约 $3M（Forbes 30 Under 30，2024-01；MIT 机械系 2025 报道写约 $4.7M；Forbes 称投资方含 DeltaV、Matter Health、MIT Venture Mentoring Fund）",
   "funding": [
    {
     "date": "2023-07",
     "round": "种子轮（金额与领投方没查到；PitchBook 聚合站列参投 Supermoon Capital、Dorm Room Fund、E14 Fund、Arben Ventures、Phoenix Investment Club）",
     "amount": "未披露",
     "src": "https://pitchbook.com/profiles/company/492676-03"
    }
   ],
   "key_data": [
    {
     "k": "NIH SBIR 资助（验证 Terra）",
     "v": "$277,391",
     "date": "2025",
     "src": "https://www.sbir.gov/awards/219280"
    },
    {
     "k": "量产与发货",
     "v": "2024 年初开始制造，2024-07 起发货；团队 8 人",
     "date": "2025-06",
     "src": "https://www.dailygood.org:443/kn/18247/engineering-better-sleep-during-menopause/"
    }
   ],
   "note": "MIT 出身（DeltaV 加速器），曾用名 AuraBlue（PitchBook）。投资方：e14、Supermoon Capital、MIT Sandbox 等，轮次、金额、领投没查到；Forbes 2024-01 写 $3M，MIT 2025 写 $4.7M。Tracxn 聚合站写 $5.38M，未采用。官网域名没核到，url 暂用 App Store 页。收入、估值没公开。成立年份取 2020（PitchBook、Tracxn），CEO 2024 访谈说 2021 年创办。"
  },
  {
   "name": "Embr Labs",
   "layer": "f6",
   "url": "https://embrlabs.com/",
   "hq": "波士顿",
   "founded": 2014,
   "product": "Embr Wave 2",
   "form": "手环·手表",
   "desc": "手腕按键冷热控温，缓解潮热、盗汗，非激素方案",
   "ai_features": "没查到 AI 功能：在售版为手动按键冷暖；第三方称自动感知的预测版仍在研发（未见公司确认）",
   "regulatory": {
    "v": "未申请（一般健康类）：零售页注明非医疗器械、未经 FDA 评估",
    "src": "https://www.kohls.com/product/prd-6422971/embr-wave-cooling-and-warming-wristband-personalized-thermal-relief.jsp?color=Black&prdPV=19"
   },
   "price_na": {
    "v": "$299 买断，或 $20/月租（翻新）/ $25/月租（全新）",
    "date": "2026-11",
    "src": "https://embrlabs.com/pages/choose-plan"
   },
   "north_america": "北美公司：官网直销（订阅仅限美国本土 48 州）+ Costco、Sam's Club、Walmart、Best Buy、Target、Optum Now；英国有 Boots",
   "stage": "在售",
   "total_raised": "累计融资约 $50M（Owler/VCBeat 聚合站口径，非公司披露；本表可核对的合计约 $42.5M）",
   "funding": [
    {
     "date": "2018-11",
     "round": "A 轮（无明确领投；参投 Social Starts、PBJ Capital、Joyance Partners、Bose Ventures）",
     "amount": "$1.5M",
     "src": "https://seedtable.com/companies/embr-labs-inc"
    },
    {
     "date": "2019-09",
     "round": "B 轮（领投方没查到；聚合站列 DigiTx Partners、PBJ Capital、Safar Partners、Bose Ventures、Social Starts）",
     "amount": "$6M",
     "src": "https://www.finsmes.com/2019/09/embr-labs-raises-6m-in-series-b-financing.html"
    },
    {
     "date": "2023-05",
     "round": "知识产权债务融资",
     "amount": "$35M",
     "lead": "GT Investment Partners（Ghost Tree Partners；Aon 协助安排）",
     "src": "https://aon.mediaroom.com/Aons-Intellectual-Property-Solutions-Help-Facilitate-a-35-Million-Loan-for-Embr-Labs"
    }
   ],
   "key_data": [
    {
     "k": "累计售出",
     "v": "超 12.5 万台，覆盖 170+ 国家",
     "date": "2024",
     "src": "https://www.safar.partners/wp-content/uploads/2025/07/1-Safar-Partners-2024-Sustainability-Report.pdf"
    },
    {
     "k": "2026-05 里程碑",
     "v": "斯坦福 POTS 患者研究（22 人）、日本专利扩展、向研究者开放 API/SDK",
     "date": "2026-05",
     "src": "https://www.owler.com/company/embrlabs"
    }
   ],
   "customers": [
    "Costco",
    "Sam's Club",
    "Walmart",
    "Best Buy",
    "Target",
    "Optum Now",
    "Kohl's",
    "Boots（英国）"
   ],
   "note": "成立年份各库不一：PitchBook 写 2013，CB Insights 与 Parsers 写 2014，这里取 2014。投资方见公司公开材料：Bose Ventures、DigiTx Partners、Safar Partners、Joy Ventures、Intel Capital。B 轮 $6M 只有聚合站来源。收入、估值没查到公开数据。FDA 状态：一份旧文称 Wave 1「FDA registered」，只查到这一条且无登记号，未采用。线索里说的「和 UMass 做 AI 潮热预测」没查到公开来源。"
  },
  {
   "name": "Thermaband",
   "layer": "f6",
   "url": "https://thermaband.com/product/zone/",
   "hq": "迈阿密",
   "product": "Thermaband Zone",
   "form": "手环·手表",
   "desc": "智能手环感知体温，自动或手动给出冷暖脉冲缓解潮热",
   "ai_features": "官网称用 AI 感知体温变化，在潮热前自动触发冷暖（没查到算法细节）",
   "regulatory": {
    "v": "未申请（一般健康类）：媒体报道称不按医疗器械销售",
    "src": "https://techacute.com/thermaband-zone-wearable-hot-flashes/"
   },
   "price_na": {
    "v": "$199（2022 预购价）+ 含 6 个月 App 订阅；现价没核到",
    "date": "2022-11",
    "src": "https://techacute.com/thermaband-zone-wearable-hot-flashes/"
   },
   "north_america": "北美公司：官网标注仅美国（US only）",
   "stage": "预售",
   "total_raised": "累计融资约 $1.5M（创始人对 BBC 自述）；CB Insights 另记 $150K 加速器资助",
   "funding": [
    {
     "date": "2023-03",
     "round": "种子（创始人对 BBC 自述；报道日期，实际融资时间与领投方没查到）",
     "amount": "$1.5M",
     "src": "https://www.bbc.com/news/business-64899189"
    }
   ],
   "note": "创始人 Debbie Dickinson 与女儿，南佛罗里达（CBS12 2022-02 报道）。成立年份没查到。官网页仍写「正在做质量控制测试」，最新媒体报道停在 2022 年，没查到发货、融资、收入数据，经营状态存疑，需要人工确认是否仍在运营。"
  },
  {
   "name": "Curiva",
   "layer": "f7",
   "url": "https://www.curiva.co/science",
   "hq": "芝加哥",
   "founded": 2020,
   "product": "diaPatch 微针诊断贴片",
   "form": "贴片",
   "desc": "微针贴片采集间质液，检测宫颈癌与卵巢癌 miRNA 标志物",
   "ai_features": "没查到 AI 功能",
   "regulatory": {
    "v": "未申请（开发中，仅计划研究用途 RUO；之后拟申请 FDA）",
    "src": "https://www.curiva.co/science"
   },
   "north_america": "北美公司（早期）",
   "stage": "研究",
   "total_raised": "没查到外部股权融资（仅创始人投入 $25K + NSF I-Corps 资助 $25K，公司 2021 执行摘要）",
   "note": "创始人 Eydis Lima（前 AbbVie）。首个适应症是宫颈异常 Pap 后的分流，卵巢癌是后续标志物。无临床数据、无价格、无估值。资料很少，融资来源是聚合站。"
  },
  {
   "name": "Cyrcadia Health",
   "layer": "f7",
   "url": "https://cyrcadiahealth.com/",
   "hq": "里诺（内华达，2017 年报道）",
   "founded": 2008,
   "product": "iTBra / Cyrcadia Breast Monitor",
   "form": "胸衣内",
   "desc": "胸衣内两片传感贴，通过乳腺组织昼夜温度变化筛查异常",
   "ai_features": "机器学习分析乳腺组织昼夜节律温度模式，识别异常并回传核心实验室出报告",
   "regulatory": {
    "v": "iTBra 本身没查到 FDA 记录；2017 年媒体称其拥有前代产品的 510(k) Class II 许可（号没查到）",
    "src": "https://www.mobihealthnews.com/news/teenage-inventors-show-prototype-cancer-detecting-bra"
   },
   "north_america": "北美公司：但官网注明「美国暂不销售」，主攻亚洲（Cyrcadia Asia 授权）",
   "stage": "临床",
   "total_raised": "累计融资约 $5.9M（Medicalstartups 聚合站，非公司口径）",
   "funding": [
    {
     "date": "2018-07",
     "round": "Pre-A 轮（Cyrcadia Asia 子公司）",
     "amount": "$3.8M",
     "lead": "iFLYTEK（科大讯飞）",
     "src": "https://biospectrumasia.com/news/46/11287/iflytek-to-develop-breast-cancer-detection-wearable-device.html"
    }
   ],
   "key_data": [
    {
     "k": "临床试验",
     "v": "计划 250 人、美国 3 个站点（El Camino Hospital 等）",
     "date": "2015-07",
     "src": "https://www.elcaminohealth.org/newsroom/cyrcadia-health-enters-clinical-trials-wearable-breast-cancer-detection-device"
    }
   ],
   "note": "前身 First Warning Systems（2008），2014 年更名并转向可穿戴。最新进展停在 2018 年前后，Crustdata 显示员工 4 人（2026-09），经营活跃度低，状态存疑。FDA 声明来自旧媒体，投资者论坛对此有争议，未采用论坛内容；FDA 数据库没检到 iTBra 条目。无价格、估值、收入。Lifeline Biotechnologies 持股信息来自股吧，未采用。"
  },
  {
   "name": "iSono Health",
   "layer": "f7",
   "url": "https://www.isonohealth.com/",
   "hq": "南旧金山",
   "founded": 2014,
   "product": "ATUSA 自动 3D 乳腺超声系统",
   "form": "系统",
   "desc": "穿戴式自动 3D 乳腺超声，约 2 分钟扫完双乳",
   "ai_features": "自动化图像采集与分析软件，做 3D 重建与病灶辅助识别（厂商口径）",
   "regulatory": {
    "v": "FDA 510(k) K213620，ATUSA 自动 3D 乳腺超声系统，2022-04-22 批准",
    "src": "https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K213620"
   },
   "north_america": "北美公司：面向医院/影像中心直销；全球南方 31 个市场由 Abdul Latif Jameel Health 独家分销",
   "stage": "在售",
   "total_raised": "累计融资约 $14.7M（含 $3.7M 非稀释性资助，Applied Radiology 报道）",
   "funding": [
    {
     "date": "2025-10",
     "round": "种子优先股（含延期；Draper、Transform 是领投还是参投，Yespress 和 Seedtable 说法不一）",
     "amount": "$3M",
     "lead": "Draper Associates、Transform VC（JSK Investments 跟投）",
     "src": "https://seedtable.com/companies/isono-health/funding-rounds/seed-2025-10"
    }
   ],
   "key_data": [
    {
     "k": "商业发布",
     "v": "2026-01-14 起商业销售，同时启动 A 轮",
     "date": "2026-01",
     "src": "https://seedtable.com/companies/isono-health/funding-rounds/seed-2025-10"
    },
    {
     "k": "扫描时间",
     "v": "双乳不到 2 分钟（传统 ABUS 约 10–15 分钟）",
     "date": "2024-01",
     "src": "https://dev.frost.com/wp-content/uploads/2024/01/iSono-Health-Award-Write-Up-1.pdf"
    }
   ],
   "customers": [
    "Abdul Latif Jameel Health（全球南方 31 市场分销）"
   ],
   "note": "成立年份 2014 来自 Yespress 聚合文章，官方来源没核到。形态是绑在检查床上患者身上的穿戴配件加床边主机，主要用于医院，非家用，请按图谱口径判断是否保留。Frost 文件称 2022-05 获批，FDA 数据库显示决定日期 2022-04-22，以 FDA 为准。价格、收入、估值没公开。"
  },
  {
   "name": "MIT 可穿戴超声胸衣（研究）",
   "layer": "f7",
   "url": "https://www.media.mit.edu/posts/canan-dagdeviren-named-one-of-worth-s-groundbreaking-women-2026/",
   "hq": "剑桥（麻省）",
   "founded": 2024,
   "product": "cUSBr-Patch（可贴合超声乳房贴片）",
   "form": "胸衣内",
   "desc": "夹在胸衣上的蜂窝状超声贴片，在家扫描全乳房影像",
   "ai_features": "计划用 AI 分析影像并向医生出具报告（研究者访谈口径，尚未上线）",
   "regulatory": {
    "v": "未申请（研究阶段）；研究者称还需约 900 人试验才能报批",
    "src": "https://t24.com.tr/saglik/mitli-turk-bilim-insanindan-meme-kanserine-karsi-giyilebilir-teknoloji-bir-fincan-kahveden-ucuz-olacak,1328806"
   },
   "north_america": "北美机构研究项目（MIT Media Lab · Conformable Decoders）",
   "stage": "研究",
   "key_data": [
    {
     "k": "2026 临床研究",
     "v": "已完成首批 100 名受试者",
     "date": "2026-05",
     "src": "https://www.egltours.com/promotion/fit_banner/actualLive.html?live-news-8811668-2026-05-24-meme-kanserini-teshis-eden-elektronik-sutyende-sona-gelindi-dunyaca-unlu-bilim-i"
    },
    {
     "k": "目标成本",
     "v": "单件低于 $3（研究者口径）",
     "date": "2026-06",
     "src": "https://t24.com.tr/saglik/mitli-turk-bilim-insanindan-meme-kanserine-karsi-giyilebilir-teknoloji-bir-fincan-kahveden-ucuz-olacak,1328806"
    },
    {
     "k": "太空测试",
     "v": "2025-04 随 Blue Origin 女性机组上太空",
     "date": "2025-04",
     "src": "https://worth.com/women/dr-canan-dagdeviren/?list_year=2026"
    }
   ],
   "note": "负责人 Canan Dagdeviren（MIT Media Lab）。首篇论文 2024 年 7 月见 Science Advances，founded 取论文年份，不是公司成立年。研究者称 2026-09 起推进公司化，没查到已成立的公司名。无融资、估值、价格数据。土耳其媒体来源（Habertürk、T24）为主流媒体采访，英文一手出处只查到 Media Lab / Worth 的概述。"
  },
  {
   "name": "Bellabeat",
   "layer": "f8",
   "url": "https://bellabeat.com/ivy",
   "hq": "旧金山",
   "founded": 2014,
   "product": "Ivy+ 手环（另有 Leaf 系列）",
   "form": "手环·手表",
   "desc": "为女性设计的珠宝式手环，追踪睡眠、压力、准备度，结合周期阶段给建议",
   "ai_features": "按心率、HRV、呼吸、体温生成每日准备度与健康评分，并给周期阶段建议",
   "regulatory": {
    "v": "未申请（一般健康类）",
    "src": "https://bellabeat.com/ivy"
   },
   "north_america": "北美公司：旧金山（Y Combinator W14，早期在克罗地亚萨格勒布有办公室）",
   "stage": "在售",
   "total_raised": "公司自称累计已融约 $1 亿、28 位投资人（Delo.si，2022-01）；聚合站 Fundbat 写约 $19M，口径差异大，一手没证实",
   "funding": [
    {
     "date": "2014-05",
     "round": "种子轮（无明确领投；参投 SV Angel、CrunchFund、Nicolas Berggruen、Universal Music Group、Cherubic Ventures、Promus Ventures 等）",
     "amount": "$4.5M",
     "src": "https://techcrunch.com/2014/05/23/bellabeat-lands-4-5m-to-grow-its-quantified-self-program-for-pregnancy/"
    },
    {
     "date": "2018-05",
     "round": "A 轮（聚合站 Nasdaq Private Market；领投方没查到，聚合站列 Bramelea Partners、Nordic Eye Venture Capital、Frontierspace Ventures）",
     "amount": "$14.2M",
     "src": "https://www.nasdaqprivatemarket.com/company/bellabeat/"
    },
    {
     "date": "2021",
     "round": "B 轮（聚合站 Forge Global，未获公司公告证实；领投方没查到，聚合站列 Bramelea Partners、Nordic Eye Venture Capital）",
     "amount": "约 $69M（B-1 $50.07M + B-2 $19M）",
     "src": "https://forgeglobal.com/bellabeat_ipo/"
    }
   ],
   "note": "官网 Ivy+ 页面仍在线，聚合站 2026-10 抓取时也写着公司在向「Ivy」订阅服务转型，但官网当前售价没取到（第三方网站零星提到 $70–100，不可靠，没采用）。Wikiwand 引用投资方说 2023 年收入 $650M，数字明显不合理，没采用。估值没查到。"
  },
  {
   "name": "Petal",
   "layer": "f8",
   "url": "https://petal.today/",
   "hq": "旧金山",
   "product": "Petal 胸衣内置传感垫",
   "form": "胸衣内",
   "desc": "放进日常胸衣，用 ECG 和生物阻抗测心率、内脏脂肪、活动、平衡",
   "ai_features": "算法只用女性数据训练，建立个人基线，提示变化；水合追踪在开发中",
   "regulatory": {
    "v": "没查到 FDA 记录（官网定位为健康产品；长期方向含乳腺癌早筛）",
    "src": "https://petal.today/"
   },
   "price_na": {
    "v": "$199（预购价曾为 $149）",
    "date": "2026-09",
    "src": "https://www.journalduweb.org/ce-petit-boitier-glisse-dans-le-soutien-gorge-veut-revolutionner-la-sante-cardiaque-des-femmes/"
   },
   "north_america": "北美公司：旧金山，2026-09 起在美国发货",
   "stage": "在售",
   "total_raised": "没查到外部融资",
   "customers": [
    "Zara Butte 博士（临床产品负责人）",
    "Nicolas Prionas 博士（首席医学官，UCSF 放射肿瘤科）"
   ],
   "note": "创始人 Anand Janefalkar 此前创办 UJet。融资、估值、收入、公司成立年份都没查到。价格来自法国媒体 Journal du Web 对官方定价的转述，没拿到官网购买页。2026-09 开始发货，来源 Femtech Insider。"
  },
  {
   "name": "Apple Watch（周期追踪）",
   "layer": "f9",
   "url": "https://support.apple.com/en-us/HT210407",
   "hq": "库比蒂诺",
   "founded": 2019,
   "product": "Apple Watch 周期追踪 + 回溯排卵估计（Series 8 起）",
   "form": "手环·手表",
   "desc": "手表夜间腕温识别双相变化，回溯估计排卵并校准经期预测",
   "ai_features": "算法结合腕温与心率数据预测经期与估计排卵（回溯式，非预测未来排卵）",
   "regulatory": {
    "v": "没查到 FDA 记录：官方 IFU 将 Cycle Tracking 列为软件、不可用于避孕，未见 510(k) 编号",
    "src": "https://www.apple.com/legal/ifu/cycle-tracking/ct-ifu-en_US.pdf"
   },
   "north_america": "北美公司",
   "stage": "在售",
   "key_data": [
    {
     "k": "周期追踪首发",
     "v": "2019-06 预览，watchOS 6 / iOS 13",
     "date": "2019-06",
     "src": "https://grokipedia.com/page/Period-Tracking_App"
    },
    {
     "k": "腕温与回溯排卵估计",
     "v": "2022-09 随 Series 8 / Ultra 推出",
     "date": "2022-09",
     "src": "https://www.theverge.com/2022/10/19/23408923/apple-fertility-cycle-app-research-rigour-pregnancy"
    },
    {
     "k": "Apple Women's Health Study 睡眠研究",
     "v": "9.4 万晚睡眠数据、338 名参与者，用于围绝经期",
     "date": "2026-05",
     "src": "https://www.mactech.com/2026/05/29/apple-and-harvard-have-published-the-apple-womens-health-study/"
    }
   ],
   "product_line_of": "Apple",
   "public": true,
   "note": "功能随 Apple Watch 销售，无单独定价；整机价格未核。2019-06 首发日期来自 Grokipedia（聚合站），Apple 官方发布稿没核到。用户规模没公开。"
  },
  {
   "name": "Garmin（女性健康追踪）",
   "layer": "f9",
   "url": "https://www.garmin.com/en-US/blog/",
   "hq": "奥拉西（堪萨斯州）",
   "founded": 2019,
   "product": "Garmin Connect 女性健康（周期追踪、孕期追踪）",
   "form": "手环·手表",
   "desc": "手表记录周期与孕期，用夜间皮温改进经期与排卵预测",
   "ai_features": "没查到 AI 功能：用皮肤温度改进经期预测与回溯排卵估计（2026 Cirqa 发布稿）",
   "regulatory": {
    "v": "没查到 FDA 记录",
    "src": "https://wearable-technologies.com/news/garmin-adds-pregnancy-tracking-alongside-health-and-wellness-for-moms-to-be"
   },
   "north_america": "总部瑞士注册、美国堪萨斯运营；美国为主要市场",
   "stage": "在售",
   "key_data": [
    {
     "k": "周期追踪首发",
     "v": "2019 年推出周期追踪",
     "date": "2019",
     "src": "https://wearable-technologies.com/news/garmin-adds-pregnancy-tracking-alongside-health-and-wellness-for-moms-to-be"
    },
    {
     "k": "孕期追踪",
     "v": "2020-11 新增",
     "date": "2020-11",
     "src": "https://wearable-technologies.com/news/garmin-adds-pregnancy-tracking-alongside-health-and-wellness-for-moms-to-be"
    },
    {
     "k": "Cirqa 无屏手环",
     "v": "2026-07 发布，支持周期/孕期追踪并同步 Natural Cycles",
     "date": "2026-07",
     "src": "https://www.fonearena.com/blog/487866/garmin-cirqa-smart-band-price-features.html/amp"
    }
   ],
   "product_line_of": "Garmin",
   "public": true,
   "note": "url 暂用 Garmin 官网博客入口，具体功能页没核到。功能随设备销售，不单独定价；用户规模没公开。"
  },
  {
   "name": "Google Pixel Watch / Fitbit（女性健康）",
   "layer": "f9",
   "url": "https://blog.google/products-and-platforms/products/google-health/commitment-womens-health-flo-health-partnership/",
   "hq": "山景城",
   "founded": 2018,
   "founded_month": "2018-05",
   "product": "Fitbit 女性健康追踪（经期预测、周期感知教练）",
   "form": "手环·手表",
   "desc": "手环与 App 记录周期，预测经期，2027 起接入 Flo",
   "ai_features": "Google Health Premium 提供周期感知的健康教练；目前经期预测主要由用户记录推算",
   "regulatory": {
    "v": "没查到 FDA 记录",
    "src": "https://blog.google/products-and-platforms/products/google-health/commitment-womens-health-flo-health-partnership/"
   },
   "north_america": "北美公司",
   "stage": "在售",
   "key_data": [
    {
     "k": "Fitbit 女性健康追踪首发",
     "v": "2018-05 在 Fitbit App 与 Versa/Ionic 上线",
     "date": "2018-05",
     "src": "https://venturebeat.com/mobile/fitbit-rolls-out-female-health-tracking-and-android-quick-replies"
    },
    {
     "k": "与 Flo Health 多年合作",
     "v": "2026-10 宣布并战略投资 Flo，计划 2027 年初双向同步数据",
     "date": "2026-10",
     "src": "https://cnbeta.stateserver.com/wap/view/1581874.htm"
    }
   ],
   "product_line_of": "Google",
   "public": true,
   "note": "founded 取 Fitbit 女性健康追踪首发年（2018，Fitbit 2021 年被 Google 收购）。Pixel Watch 上的具体周期功能首发时间没核到。Flo 合作细节中文转述自 cnBeta，英文原稿为 Google 官方博客。无单独价格和用户规模数据。"
  },
  {
   "name": "Oura",
   "layer": "f9",
   "url": "https://ouraring.com/blog/hormonal-health-features/",
   "hq": "奥卢（芬兰）/ 旧金山",
   "founded": 2022,
   "founded_month": "2022-10",
   "product": "Oura Ring（Period Prediction → Cycle Insights → Menopause Insights）",
   "form": "戒指",
   "desc": "戒指用夜间皮温预测经期，2026 起加入激素避孕与更年期洞察",
   "ai_features": "温度趋势预测经期，Menopause Insights 用 22 症状量表加生物数据生成个性化解读",
   "regulatory": {
    "v": "未申请（一般健康类）：Oura 无 FDA 许可，Natural Cycles 自有许可",
    "src": "https://www.circadian.news/wearables/oura/"
   },
   "price_na": {
    "v": "会员 $5.99/月 或 $69.99/年（美国）；戒指现价没从官网核到",
    "date": "2026-10",
    "src": "https://support.ouraring.com/hc/en-us/articles/42984195317779-Retail-Purchases"
   },
   "north_america": "北美主推：美国为主要市场，渠道含 Best Buy、Target、Costco、亚马逊",
   "stage": "在售",
   "valuation": {
    "v": "约 $11B（IPO 定价区间对应完全摊薄 $15.62B，已推迟）",
    "date": "2025-10",
    "kind": "投后估值，公司口径",
    "src": "https://techcrunch.com/2025/10/14/smart-ring-maker-oura-raises-900m-from-fidelity/"
   },
   "revenue": {
    "v": "$1.21B（截至 2026-06-30 的九个月，同比 +74%），净利润 $60.8M",
    "date": "2026-06",
    "kind": "招股文件披露，路透计算",
    "src": "https://www.forbes.com.au/news/investing/oura-sets-terms-for-up-to-2-2-billion-ipo/"
   },
   "total_raised": "累计融资约 $14.5 亿（2024-12 公司口径超 $5.5 亿 + 2025-10 E 轮 $9 亿+，本表相加）",
   "funding": [
    {
     "date": "2018-07",
     "round": "A 轮追加",
     "amount": "€5M（约 $5.9M）",
     "lead": "Bold Capital Partners、Tesi",
     "src": "https://www.finsmes.com/2018/07/healthtech-startup-oura-health-raises-e5m-closes-e12-5m-round.html"
    },
    {
     "date": "2020-03",
     "round": "B 轮",
     "amount": "$28M",
     "lead": "Forerunner Ventures（Gradient Ventures、Square 跟投）",
     "src": "https://mercomcapital.com/oura-ring-raises-28-million-in-series-b-funding/"
    },
    {
     "date": "2021-05",
     "round": "C 轮",
     "amount": "$100M",
     "lead": "The Chernin Group、Elysian Park Ventures（Temasek、Jazz Venture Partners、Eisai、Bedford Ridge Capital、One Capital、Square、Forerunner Ventures、MSD Capital、Lifeline Ventures 跟投）",
     "post": "投后约 $800M（Forbes 援引知情人）",
     "src": "https://globalventuring.com/blog/2021/05/06/oura-obtains-100m-in-series-c/"
    },
    {
     "date": "2022-04",
     "round": "增长轮（金额与领投方没查到）",
     "amount": "未披露",
     "post": "投后 $2.55B",
     "src": "https://vc.ru/invest/1719222-proizvoditel-umnyh-kolec-oura-zakryl-investraund-na-200-mln-pri-ocenke-52-mlrd"
    },
    {
     "date": "2024-12",
     "round": "D 轮（2024-11 Dexcom 先投 $75M，12 月 Fidelity 追加）",
     "amount": "$200M",
     "lead": "Fidelity Management & Research Company、Dexcom",
     "post": "投后 $5.2B",
     "src": "https://techcrunch.com/2024/12/19/oura-closes-200m-round-bringing-its-valuation-to-5-2b/"
    },
    {
     "date": "2025-10",
     "round": "E 轮",
     "amount": "$900M+",
     "lead": "Fidelity Management & Research Company（ICONIQ、Whale Rock、Atreides 跟投）",
     "post": "投后约 $11B",
     "src": "https://techcrunch.com/2025/10/14/smart-ring-maker-oura-raises-900m-from-fidelity/"
    }
   ],
   "key_data": [
    {
     "k": "累计售出",
     "v": "超 550 万枚戒指",
     "date": "2025-10",
     "src": "https://pitchbook.com/news/articles/ouras-valuation-doubles-to-11b-as-health-tracking-heats-up"
    },
    {
     "k": "Period Prediction 首发",
     "v": "2022-10 上线，2023 秋升级为 Cycle Insights",
     "date": "2023-10",
     "src": "https://ouraring.com/blog/ouras-commitment-to-prioritizing-womens-health/"
    },
    {
     "k": "Menopause Insights",
     "v": "2026-04-30 宣布，05-06 起分批推送",
     "date": "2026-05",
     "src": "https://www.mobihealthnews.com/news/oura-unveils-menopause-insights-birth-control-tools-us-open-partnership"
    }
   ],
   "customers": [
    "Natural Cycles（体温数据接入）",
    "Twentyeight Health（避孕处方）",
    "Cronometer"
   ],
   "note": "独立公司，founded 取女性功能首发（2022-10）而非公司成立（2013）。2026-05 保密递交 IPO，定价区间 $40–44，但 2026-09-29 宣布推迟，目前仍是私有公司。戒指现价没从官网核到（第三方称 Ring 4 约 $349）。Menopause Insights 仅支持 Ring Gen3 / Ring 4。"
  },
  {
   "name": "Samsung Galaxy Watch / Ring（周期追踪）",
   "layer": "f9",
   "url": "https://www.samsung.com/us/support/answer/ANS10004563/",
   "hq": "首尔",
   "founded": 2023,
   "founded_month": "2023-02",
   "product": "Samsung Health 周期追踪（Galaxy Watch5 起、Galaxy Ring）",
   "form": "手环·手表",
   "desc": "手表与戒指夜间皮温提升经期、排卵窗预测精度",
   "ai_features": "温度周期算法由 Natural Cycles 提供；根据皮温与经期历史预测下次经期和排卵",
   "regulatory": {
    "v": "没查到 FDA 记录：三星称不用于避孕，预测仅供个人参考",
    "src": "https://www.mobihealthnews.com/news/samsung-natural-cycles-partner-add-temperature-based-period-tracking-galaxy-watch5"
   },
   "north_america": "总部在外，北美为主要市场：美国、加拿大 Samsung Health 均提供该功能（官方支持页）",
   "stage": "在售",
   "key_data": [
    {
     "k": "合作发布",
     "v": "2023-02 宣布与 Natural Cycles 合作，二季度在含美国在内的 32 个市场上线",
     "date": "2023-02",
     "src": "https://www.mobihealthnews.com/news/samsung-natural-cycles-partner-add-temperature-based-period-tracking-galaxy-watch5"
    }
   ],
   "product_line_of": "Samsung",
   "public": true,
   "note": "功能随设备销售，不单独定价；整机价格未核。Galaxy Ring 同样支持。Natural Cycles 的温度算法授权，本身是 FDA 批准的避孕 App，但三星这条功能不是避孕用途。用户规模没公开。"
  },
  {
   "name": "Ultrahuman Ring（Cycle & Ovulation Pro）",
   "layer": "f9",
   "url": "https://www.ultrahuman.com/ring/",
   "hq": "班加罗尔",
   "founded": 2025,
   "founded_month": "2025-08",
   "product": "Cycle & Ovulation Pro（Ring Air 插件）",
   "form": "戒指",
   "desc": "戒指用皮温确认排卵，识别早排卵晚排卵，辅助 PCOS 人群",
   "ai_features": "温度算法源自 viO 的 OvuSense，基于 26 万+ 周期的医疗级传感数据训练",
   "regulatory": {
    "v": "没查到 FDA 记录",
    "src": "https://techcrunch.com/2025/08/15/ultrahuman-acquires-vio-healthtech-to-launch-enhanced-cycle-and-ovulation-tracking/"
   },
   "price_na": {
    "v": "$3.99/月 或 $39/年（插件）",
    "date": "2025-08",
    "src": "https://tech.yahoo.com/wearables/articles/ultrahumans-cycle-ovulation-pro-ring-160200451.html"
   },
   "north_america": "总部在印度，北美主推：美国占季度收入约 45%，是最大市场；2026 年重新进入美国市场（Ring Pro），在德州普莱诺有制造点",
   "stage": "在售",
   "valuation": {
    "v": "$365M",
    "date": "2026-09",
    "kind": "估值，媒体报道（约为 2023 年 $120M 的 3 倍）",
    "src": "https://techfundingnews.com/qualcomm-ventures-ultrahuman-70-million-ai-smart-ring/"
   },
   "revenue": {
    "v": "年化收入约 $1.4 亿（同比约 +45%）",
    "date": "2026-09",
    "kind": "run rate，媒体转述公司口径",
    "src": "https://techbeat.co/story/qualcomm-backs-ultrahuman-s-70m-push-to-turn-smart-rings-into-computers"
   },
   "total_raised": "累计约 $135M（Economic Times 2024-03 口径 $65M + 2026-09 C 轮 $70M，含债务）",
   "funding": [
    {
     "date": "2021-08",
     "round": "A 轮",
     "amount": "$17.5M",
     "lead": "Alpha Wave Incubation、Steadview Capital（Nexus Venture Partners、Blume Ventures、iSeed 跟投）",
     "src": "https://economictimes.indiatimes.com/tech/startups/healthtech-startup-ultrahuman-acquires-wearables-firm-lazyco/articleshow/90797821.cms"
    },
    {
     "date": "2024-03",
     "round": "B 轮（股权约 $25M + 债务）",
     "amount": "$35M",
     "lead": "Blume Ventures、Steadview Capital、Nexus Venture Partners（Alpha Wave Global、Deepinder Goyal 跟投）",
     "src": "https://economictimes.indiatimes.com/tech/funding/health-device-maker-ultrahuman-raises-35-million-led-by-steadview-nexus/articleshow/108646994.cms"
    },
    {
     "date": "2026-09",
     "round": "C 轮（$65M 股权 + $5M 债务）",
     "amount": "$70M",
     "lead": "Qualcomm Ventures（Labcorp、Alpha Wave、Blume Ventures、Nexus Venture Partners、Alteria Capital 跟投）",
     "post": "投后约 $365M",
     "src": "https://techfundingnews.com/qualcomm-ventures-ultrahuman-70-million-ai-smart-ring/"
    }
   ],
   "key_data": [
    {
     "k": "累计售出",
     "v": "约 80 万枚戒指",
     "date": "2026-09",
     "src": "https://techbeat.co/story/qualcomm-backs-ultrahuman-s-70m-push-to-turn-smart-rings-into-computers"
    }
   ],
   "note": "独立公司，founded 取插件首发年。2025-08 收购女性健康公司 viO HealthTech（金额未披露）获得算法；2025-08 因 Oura 专利案被美国 ITC 禁止进口，2026-03 以重新设计的 Ring Pro 重返美国。Ring Pro 价格 $479 仅见第三方报道，未采用。资料来源里 C 轮金额与估值以二手媒体为主，TechCrunch 原文没打开。"
  },
  {
   "name": "Whoop（周期与孕期洞察）",
   "layer": "f9",
   "url": "https://www.whoop.com/gb/en/press-center/whoop-broadens-whoop-advanced-labs-offering/",
   "hq": "波士顿",
   "founded": 2021,
   "founded_month": "2021-11",
   "product": "WHOOP 5.0 / MG 手环（Menstrual Cycle Insights、Pregnancy Insights、荷尔蒙症状预测）",
   "form": "手环·手表",
   "desc": "手环按周期阶段调整训练与恢复建议，2026 增加症状预测",
   "ai_features": "用睡眠、皮温、压力等数据建模周期，预测荷尔蒙症状；AI 教练提供女性健康问答",
   "regulatory": {
    "v": "没查到 FDA 记录：官方注明周期洞察不是医疗器械、不可用于避孕或备孕",
    "src": "https://www.whoop.com/us/en/membership/?correlationId=0f46241d-8f02-447f-8538-2b4ff7bca6bc&rvo_aff=1&rvo_brandid=WHOOP&rvo_prodid=fd798fa3-5580-40c1-a0d4-cb95dd30689e&rvo_subid=fd798fa3-5580-40c1-a0d4-cb95dd30689e&rvo_subid2=%2Fnutrition%2Fbest-heart-rate-monitoring-watch&correlationId=a28e3b21-01fb-43cb-b4c1-1d669f16370f"
   },
   "price_na": {
    "v": "WHOOP One $199/年（首年 $149）；Peak $239/年；Life $359/年",
    "date": "2026-05",
    "src": "https://support.whoop.com/s/article/Membership-Pricing?language=en_US"
   },
   "north_america": "北美公司：美国为主市场，官网直销；Advanced Labs 仅限美国",
   "stage": "在售",
   "valuation": {
    "v": "$10.1B",
    "date": "2026-03",
    "kind": "投后估值，公司口径",
    "src": "https://news.crunchbase.com/venture/wearable-fitness-tech-ai-whoop-seriesg-funding/"
   },
   "revenue": {
    "v": "年化收入约 $11 亿（2025 订阅与预订同比 +103%）",
    "date": "2025",
    "kind": "年化 run rate，公司自报",
    "src": "https://thenextweb.com/news/whoop-series-g-575m-valuation-ipo-health-platform"
   },
   "total_raised": "累计融资超 $9 亿（Crunchbase News）",
   "funding": [
    {
     "date": "2015-09",
     "round": "B 轮（聚合站 Crustdata）",
     "amount": "$12M",
     "lead": "Two Sigma Ventures",
     "src": "https://profiles.crustdata.com/company/whoop"
    },
    {
     "date": "2018-03",
     "round": "C 轮",
     "amount": "$25M",
     "lead": "UAE71 Capital（NFLPA、Durant Company、Thursday Ventures、Two Sigma Ventures、Accomplice、Mousse Partners、Promus Ventures、NextView Ventures 跟投）",
     "src": "https://globalventuring.com/blog/2018/03/09/investors-pass-25m-to-whoop/"
    },
    {
     "date": "2019-11",
     "round": "D 轮（股权加债务）",
     "amount": "$55M",
     "lead": "Foundry Group（Two Sigma Ventures、Accomplice、Thursday Ventures、Promus Ventures、Silicon Valley Bank 跟投）",
     "src": "https://techcrunch.com/2019/11/12/whoop-sports-tech-company-that-makes-discreet-wearables-raises-55m/"
    },
    {
     "date": "2020-10",
     "round": "E 轮",
     "amount": "$100M",
     "lead": "IVP（SoftBank Vision Fund 2、Accomplice、Two Sigma Ventures、Collaborative Fund、Thursday Ventures、NextView Ventures、Promus Ventures、Cavu Ventures、D20 Capital、LionTree Partners 跟投）",
     "post": "投后 $1.2B",
     "src": "https://news.crunchbase.com/venture/briefing-10-28-20/"
    },
    {
     "date": "2021-08",
     "round": "F 轮",
     "amount": "$200M",
     "lead": "SoftBank Vision Fund 2（IVP、Thursday Ventures、Accomplice、Animal Capital、NextView Ventures、GP Bullhound 跟投）",
     "post": "投后 $3.6B",
     "src": "https://globalventuring.com/corporate/whoop-runs-to-200m-series-f/"
    },
    {
     "date": "2026-03",
     "round": "G 轮",
     "amount": "$575M",
     "lead": "Collaborative Fund（Qatar Investment Authority、Mubadala、2PointZero、Abbott、Mayo Clinic 等跟投）",
     "post": "投后 $10.1B",
     "src": "https://news.crunchbase.com/venture/wearable-fitness-tech-ai-whoop-seriesg-funding/"
    }
   ],
   "key_data": [
    {
     "k": "会员数",
     "v": "超 250 万",
     "date": "2026-03",
     "src": "https://thenextweb.com/news/whoop-series-g-575m-valuation-ipo-health-platform"
    },
    {
     "k": "女性新会员占比",
     "v": "同比增长 150%",
     "date": "2026-03",
     "src": "https://www.miragenews.com/whoop-unveils-womens-health-biomarker-panel-1634204/"
    },
    {
     "k": "周期教练首发",
     "v": "2021-11 推出 Menstrual Cycle Coaching",
     "date": "2021-11",
     "src": "https://www.sportsbusinessjournal.com/Daily/Issues/2021/11/30/Technology/whoop-announces-new-menstrual-cycle-coaching-app-for-athletes/?issueId=TDOR2X5HYIDTKAXVKZMGQ4WYYI"
    }
   ],
   "note": "独立公司（2012 年创立），founded 取周期功能首发年。创始人称 G 轮是最后一轮私募，下一步 IPO。2026-03 新增女性专属血检面板（11 项指标，Advanced Labs）与荷尔蒙症状洞察与预测。孕期洞察的首发日期没核到。"
  }
 ]
}